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TITANIA NANOTUBE ARRAYS AS POTENTIAL INTERFACES FOR NEUROLOGICAL 
PROSTHESES 
 
Neural prostheses can make a dramatic improvement for those suffering from visual and 
auditory, cognitive, and motor control disabilities, allowing them regained functionality by the 
use of stimulating or recording electrical signaling. However, the longevity of these devices is 
limited due to the neural tissue response to the implanted device. In response to the implant 
penetrating the blood brain barrier and causing trauma to the tissue, the body forms a to scar to 
isolate the implant in order to protect the nearby tissue. The scar tissue is a result of reactive 
gliosis and produces an insulated sheath, encapsulating the implant. The glial sheath limits the 
stimulating or recording capabilities of the implant, reducing its effectiveness over the long term. 
A favorable interaction with this tissue would be the direct adhesion of neurons onto the contacts 
of the implant, and the prevention of glial encapsulation. With direct neuronal adhesion the 
effectiveness and longevity of the device would be significantly improved. Titania nanotube 
arrays, fabricated using electrochemical anodization, provide a conductive architecture capable 
of altering cellular response. This work focuses on the fabrication of different titania nanotube 
array architectures to determine how their structures and properties influence the response of 
neural tissue, modeled using the C17.2 murine neural stem cell subclone, and if glial 
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 This research evaluates the efficacy of titania nanotube arrays for use in chronic 
neurological prosthesis by using nano topography to reduce glial encapsulation and promote 
direct neuron adhesion. Neural prostheses are growing in popularity as a means to treat different 
neurological ailments such as auditory or visual loss, cognitive neurodegenerative diseases, as 
well as loss of motor control. However the effectiveness and longevity of these devices have 
been limited by the immune response. Here nanotube arrays are researched as a way to reduce 
the immune response and increase the effectiveness and longevity of neural prostheses. It has 
been shown that neuronal cells like to grow and differentiation on electrically conductive 
surfaces, which is also the main function of these neurological implants. As the size of these 
implants is reduced to minimize trauma, there conductance is also decreased, thus nano 
architectures such as nanotube developed on conductive surfaces may be used to increase the 
surface area of the contacts on theses implants. While previous research has evaluated 
biodegradable conductive polymers for similar uses, these prostheses are chronic, and must 
remain stable over a long period of time. Therefore commercially pure titanium was used as a 
control with nanotube arrays of titania being studies and compared to the previously studied 
biodegradable polycaprolactone nanowire interface. Two topographies of titania nanotubes were 
fabricated using a electrochemical anodization process with a fluoride containing electrolyte. 
Both of these topographies remained conductive due to their crystal structure and reduced 
electron free path length. The first titania nanotube arrays were densely packed, and highly 
ordered with coincident walls, forming a continuous plane of nanotubes. The second titania 
nanotube arrays formed vertically oriented, high aspect ratio, uniform nanotubes that would 
bundle together forming an anemone-like architectures. In this research the physiological 
 2 
response of neural tissue to titania nanotube arrays was investigated. Adsorption of blood 
proteins albumin and fibrinogen as well as neuronal adhesion protein laminin were studied to see 
how readily they could adsorb implantation and alter the function of the surface. The murine 
neural stem cell subclone C17.2 was used as a model cell line to study cellular interaction. The 
time points were selected based on cell-specific adhesion, proliferation, and differentiation. This 
work has investigated ability of the nano topography to induce cellular differentiation as well as 
the affect of the nano topography on specific cell types was studied. These studies were chosen 
to see whether glial scare tissue encapsulation or direct neuronal adhesion of the surface was the 
prevalent outcome.  
 This work has been arranged into two specific aims. Specific aim one focuses on the 
fabrication of two different architectures of nanotube arrays as well as the characterization of 
their material, mechanical, and electrical properties as well as their adsorption of proteins that 
may be encountered during prosthesis implantation. The second of these aims looks to identify 
the response of neural tissue via a model cell line with these interfaces for chronic neural 
prostheses. Physiological response is characterized by the cellular interaction with the surface 
including adhesion, proliferation, cell viability, and eventual protein expression measured by 
immunofluorescence to understand how the different neural cell lineages are influenced by the 
surface. Through this research titania nanotube arrays are investigated for use as interfaces for 
chronic neural prostheses for uses such as auditory and visual, cognitive, and motor control 
implants.  
 This master’s thesis addresses the hypothesis that titania nanotube arrays may provide a 
conductive biomimetic interface that promotes favorable neural interaction. The conclusion of 
this research indicates that titania nanotube array topography and material properties greatly 
 3 
affect cellular interaction. Nanotube arrays with high concentration of anatase crystallinity and 
topographies of various scales providing lower moduli and surface hardness can increase direct 
neuron adhesion and limit reactive gliosis. This evidence is a promising lead that the use of 
similar titania nanotube arrays as interfaces on prostheses in contact with neural tissue may 
increase the effectiveness and longevity of chronic neurological implant.  
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Fundamental Hypothesis:  Titania nanotube arrays provide an advantageous interface for 
neurological prostheses 
 
Hypothesis 1:   
Specific Aim 1:  Fabrication and characterization of substrate immobilized arrays of titania 
nanotubes as interfaces for neurological prostheses. This specific aim is 
discussed in detail in Chapter 2 and will cover the following: 
(a) Fabrication of well-controlled, reproducible titania nanotube arrays of 
different topographies using an electrochemical anodization process.  
(b) Characterization of the different titania nanotube arrays.  
(c) Evaluation of key protein adsorption encountered during device 
implantation on titania nanotube arrays. 
 
Hypothesis 2:  Titania nanotube topographies may provide advantageous interfaces for 
prosthetic devices that are in contact with neural tissue. 
Specific Aim 2:  Investigate neural stem cell adhesion, proliferation and differentiation on 
titania nanotube arrays. This specific aim is discussed in detail in Chapters 
3 and 4 and will cover the following:  
(a) Evaluation of the effect of titania nanotube array topography on the 
adhesion, proliferation, viability, cytoskeletal organization, and 
morphology of murine neural stem cell subclone C17.2 
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(b) Differentiation of murine neural stem cell subclone C17.2 into 









Neural prostheses have become ever more common, being used to treat auditory and visual 
loss, neurodegenerative diseases, psychological disorders, as well as motor control through 
microelectrode arrays recording neural activity and directing prosthetic devices. While many of 
these areas have less invasive techniques that do not penetrate the blood brain barrier, those 
techniques do no have the accuracy and resolution provided by direct neural stimulation and 
monitoring. Neural stimulation and monitoring may also be necessary to bypass broken neural 
networks that the less invasive techniques are incapable of doing. Stimulation of areas of the 
midbrain or brainstem has restored hearing to some who have lost it from disease or trauma. Vast 
arrays of devices have been tested to simulate or recover eyesight along various stages of the 
optical pathway. Neural prostheses in the form of deep brain stimulation have been proven to 
reduce symptoms of Parkinson’s disease, multiple sclerosis, Huntington’s disease, as well as 
various psychological conditions, however the mechanisms by which these implants work are 
unknown. Proposed mechanisms state that the electrical impulses provided by these implants 
may interfere with degenerative neurons or cause neural repair, even triggering neural stem cell 
differentiation. Similar devices placed in motor cortex regions can record neuronal signaling and 
through complex programming and circuitry, reestablish motor control in paralysis patients and 
amputees in the form of motorized prosthetics. The longevity of all these direct chronic neural 
implants is limited due in part to electrode degradation and fibrous glial encapsulation resulting 
from immune response. The development of surfaces to limit the reactive glial encapsulation will 
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greatly extend the life of these implants. With a better biological integration the benefit of these 
prostheses is astounding. 
 
1.2 Neural Prosthetics 
 
1.2.1 Auditory and Visual Prosthetics 
 
One of the most common neural prosthetics is for the augmentation of auditory and visual 
cues for those with impairments. Auditory neural prostheses are divided into cochlear implants, 
auditory brain stem implants, and auditory midbrain implants. While the former is not directly 
implanted in the brain; each of these implants directly stimulates the nerves of their respective 
location to allow for the processing of sound that is otherwise limited in the individual. Auditory 
prostheses have a long history dating back to 1957 1. The first implants were short lived with 
limited but notable success. Research progressed over the next quarter century, and by 1984 
cochlear implants were approved by the Food and Drug Administration. 
The more invasive forms of neural stimulation, auditory brainstem implants (ABI) and 
auditory midbrain implants (AMI), are more limited in use due the implantation of the electrode 
into the brain rather than the cochlea. These implants are generally used when direct stimulation 
of the cochlea is not beneficial 2-4. The limited use of these implants is also a result of the 
technology, as direct stimulation of the nerve bypasses the auditory to electrical transition 
occurring in the ear, and thus must go through a processor before stimulating the nerve 5. 
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Figure 1.2.1: Auditory prosthesis showing stimulation of the cochlea as well as an auditory 
brainstem implantable electrode. Reprinted from Hearing Research, Volume 242, Issues 1-2, 
Blake S. Wilson, Michael F. Dorman, Cochlear implants: A remarkable past and a brilliant 
future, page 6, copyright (2008), with permission from Elsevier. Diagram courtesy of MED-EL 
Medical Electronics GmbH, of Innsbruck, Austria 1. 
 
 In the case of damage or disease to the optical pathway, electrical stimulation of different 
neuronal populations can allow for visual neural augmentation 6-7. Most damage and disease only 
affect the sensory organ while the rest of the visual pathway remains intact for those with 
previously visual function 8. Among all visual prostheses an imaging system is used to acquire 
and process the signal before being transmitted to the implant. The complexity of the visual 
system leads to large microelectrode array implants. The first permanent retinal prosthesis was 
implanted in 2000 and contained a 3500 element micro-photodiode array 9. Devices like these 
stimulate the optic nerve avoiding complicated cranial surgeries. If ganglionic cells are damaged 
stimulation of deeper structures are necessary and are harder to effectively stimulate 7. Research 
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has found that some areas can be stimulated by trans cranial magnetic stimulation that reduce 
surgical complication, but are unable to fully transmit processed images 10-12. A great deal of 
research has been done on direct micro stimulation of the neural populations 10, 13-18. Pitfalls of 
all direct stimulation electrodes are their degradation over time due to immune response to the 
implant, and this further research is needed to increase the effectiveness and longevity of these 
devices.   
 
1.2.2 Cognitive Prosthetics 
 
One of the most remarkable uses of neural prostheses is their rehabilitation to individuals 
who have diminished cognitive function, whether due to trauma or disease. Neural prostheses 
have been used in deep brain stimulation to alleviate the symptoms associate with Parkinson’s 
Disease, hippocampal detriments such as Alzheimer’s disease and dementia, epilepsy, Multiple 
Sclerosis, Lou Gehrig’s disease and neuropsychiatric disorders 19-21. 
Movement disorders such as Parkinson’s disease (PD) result when neuronal populations 
degenerate, depleting other areas of dopamine and cause those areas to become over active 22. It 
is estimated that by 2030 between 8.7 and 9.3 million people world wide will be living with PD 
23, making it the second most common neurodegenerative disease. The primary symptoms of 
Parkinson’s disease include rest tremor in the distal part of extremities, bradykinesia or slowness 
of movement, muscle rigidity, and posturnal instability or impaired balance and coordination 24. 
Surgical techniques for reducing the symptoms have been developed to avoid undesirable 
side effects of many medications. One of the more intrusive surgical techniques used to control 
the symptoms of PD is ablation, or removal specific areas of neural tissue. No matter the area, 
the ablation technique had a high rate of post-operative complication and morbidity, and was 
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thus mostly abandoned by the 1970’s in favor of a drug therapy using the dopamine precursor L-
DOPA which lowered complications, but still has significant side affects 25. 
Technology progressed into the late 20th century and surgical techniques saw resurgence. 
Surgery moved away from ablative surgery and towards electrical stimulation, such as deep brain 
stimulation (DBS).  By 1993 bilateral high-frequency stimulation of the subthalamic nucleus 
became available for PD patients with additional stimulation sites pursued in the years following 
26. This technique aims to block the function of the targeted neural tissue through continuous 
electrical pulsation rather than removing the target tissue 27. This less obtrusive surgery avoids 
purposeful destruction of tissue and as such may prevent additional cognitive impairment such as 
dementia which is found in up to 20% of PD patients. Electrical stimulation has the ability to be 
tuned at multiple device contacts for maximum effect 22. In DBS an electrode is precisely 
implanted into the target brain area and is connected to a programmable pacemaker under the 
chest. Stimulation is provided through any of the four or more contacts on the distal end of the 
electrode, and pulse settings may be adjusted post-operatively, tuning the voltage amplitude, 
pulse width, and frequency 25. Stimulation operating conditions using monopolar cathodic 
stimulation are 1-5V at 120-180Hz with a pulse width of 60-200 µs 25. During implantation the 
region may be electro physiologically explored through the use of micro recording firing patterns 
and performing test stimulations 28-31. The micro recording process is controversial as it may 
increase surgical risk of hitting a blood vessel as well as increase operation time, although it may 
increase targeting confidence 25. Failure through lead extension fraction, lead migration, short or 
open circuits, pulse generator malfunction, skin erosion or infection count for upwards of 25% of 
DBS failures, but were greatly reduced with surgeon experience 32-34. However, the main issue 
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with deep brain stimulation is the immune response to the implant, which limits the ability to 
electrically stimulate the target neural population.  
 
 
Figure 1.2.2: Graphic indicating basic layout of deep brain stimulation implant and main 
targeted areas. Reprinted with permission from the Cleveland Clinical Journal of Medicine 
(CCJM), figure 1 from “Deep brain stimulation reduces symptoms of Parkinson disease” 
appearing on page 10 of CCJM’s January 1999 issue 22.  
 
Alzheimer’s disease (AD) is another neurodegenerative disease in which proteins build 
up neural tissue 35. These deposits limit the functionality of neurons leading to their 
degeneration. Neuronal death progresses affecting areas such as memory formation. As of 2006 
there were 26.6 million individual with AD with that number predicted to grow to over 100 
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million by 2050 36. Electrical stimulation through deep brain stimulation has proven promising 
for AD 37, and may provide relief for many other neurological disorders.  
 
1.2.3 Sensory and Motor Brain-Machine Interface Prosthetics 
 
Neural implants may be used to translate sensation or movement through a brain-machine 
interface (BMI) or brain-computer interface (BCI) to restore motor control for patients suffering 
debilitating conditions such as amyotrophic lateral sclerosis (ALS), spinal cord injury, stroke, 
cerebral palsy, as well as amputation 38. For motor control these devices include three 
components, the recording electrodes (invasive or non-invasive), the algorithm used to interpret 
and process the neural signal, and the object that the motor control is being sent to, referred to as 
the effector 38-39. Demonstration of the BMI first took place in 1999 40 and research efforts have 
since continued to grow. 
Recording of action potentials can be scaled from single neurons to groups of neurons 
when implanting microelectrode arrays into the cortex. These recording devices capture action 
potentials as signal spikes and local field potentials from neurons near the electrode contact 39. 
Invasive techniques were studied beginning in the 1970’s with monkey models 41-42. It was later 
hypothesized that voluntary motor commands could be processed to control prosthetic devices 
and restore motor functions 43. Recent developments have demonstrated their use in controlling 
primate limbs for reaching and grasping actions 44. Feedback mechanisms using position and 
pressure sensors could allow for complete efficient assimilation of a prosthetic device with 
feedback control 38. 
Less invasive techniques have also been used for BMIs by applying electrodes to the 
scalp, but only provide low resolution, and slow processing speeds 39. Low resolution and speed 
 13 
of these methods limit their ability in multiple degree-of-freedom limb prosthesis and can only 
be used for simple outputs such as cursor control 38, 45-46.  
 
 
Figure 1.2.3: Schematic illustrating two potential applications of a brain-machine interface. (a) 
A system to monitor and respond to a patient’s seizure activity providing necessary medication 
via a mini pump. (b) Electrode arrays analyze and interpret neuronal activity to control a 
prosthetic limb.  Reprinted by permission from Macmillian Publishers Ltd: [Nature] (Actions 
from: thoughts) copyright (2001) 47. 
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1.3 Neurophysiological Response to Implanted Devices 
 
Whenever penetrating tissue, implant size is of critical importance. This is especially true 
when entering neurological tissue where target regions amount to only a few millimeters 48. For 
this reason miniature neural prostheses have been to help pinpoint target areas as well as limit 
tissue damage 49-50. Complex three-dimensional electrode arrays have even been developed 
ranging in size from 10 to 100’s µm 51-54. No matter the size, long-term functionality of these 
implants is limited by the physiological response to the implant. Neural prostheses will 
eventually undergo cellular encapsulation, also known as fibrosis or reactive gliosis, which 
electrically 55 and mechanically segregates the prosthesis from its intended tissue and can be seen 
in Figure 1.3.1 51, 56-59. The distance between the device and target tissue has a significant affect 
on signal quality 60. Cellular encapsulation is often quantified by the increased expression of glial 
fibrillary acidic protein (GFAP) by astrocytes or astroglia. These cells are known to assist in the 
formation of the blood brain barrier and play a role in the repair and scarring of neural tissue post 
trauma 61-65. Upon insertion, physiological response is diffuse and widespread. Affected areas 
range up to 200µm around the devices, and over time becomes more concentrated around the site 
up to 50µm and well adhered to the implant 48. This compact sheath of astrocytes is sustained 
throughout the life of the implant. Different geometries, sizes, micrometer surface roughness as 
well as insertion methods 48 have been tested as a means to reduce reactive gliosis. Thus far only 
overall device size has been shown to have significant impact 48.  
Apart from the immune response, electrical stimulation of neural tissue has been suspected of 
affecting the effectiveness of the implant. This phenomenon coined “stimulus induced depression 
of neuronal excitability” (SIDNE) may explain the increased threshold for neuronal firing with 
implant time and is a function of stimulus frequency, magnitude, and selectivity 60, 66-69. By 
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limiting the glial encapsulation of the electrode and promoting direct neuronal adhesion onto the 
prosthesis signaling and recording resolution and efficiency can be greatly increased, and low 
magnitude electrical stimulation may be used to accomplish the same effect, diminishing the 





Figure 1.3.1: Stratification of cellular immunoreactivity at the microelectrode neural tissue 
interface. Images are from in vivo studies four weeks after implantation. Foreign body response 
is indicated by the minimally overlapping inflammatory (ED1) and astrocytic (GFAP) 
phenotypes near the implant interface (orange ellipse). The reactive area shows decreased 
neuronal bodies (NeuN) and a loss of neuronal filament (NF). Images were captured in grayscale 
and pseudocolored for illustrative purpose. Reprinted from Experimental Neurology, Volume 
195, Issues 1, Roy Biran, Cavid C. Martin, Patrick A. Tresco, Neuronal cell loss accompanies the 
brain tissue response to chronically implanted silicon microelectrode arrays, page 124, copyright 
(2005), with permission from Elsevier 70. 
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1.4 Nanomaterials and Biocompatability 
Nanomaterials or nanomeric surface modified materials are engineered materials with the 
smallest functional organization in the range of 1 to ~100nm in at least one dimension. Bottom 
up and top down processes are utilized to manufacture such materials. The bottom up approach 
builds nano structures by building them up from atomic or molecular scale components, and 
includes self-assembly and molecular patterning. The top-down method reduces bulk material to 
a nano architecture and includes etching, and nanolithography. Materials of this scale have great 
promise in a variety of biological applications. The reason for their promise is the hierarchical 
structure emulating natural tissue. This structure provides numerous nano sized interactions sites 
when integrated on micro and macro surfaces 71-73. Structures of this size may change the 
localized forces of the material seen by the cell as portrayed in Figure 1.4.1. These 
characteristics are critical as cells are in constant contact with nanomeric subcellular structures, 




Figure 1.4.1: Illustrations showing material strain and tissue stiffness. A) the strain distribution 
modeled for a soft material beneath a cell. B) Moduli range of soft tissue 74.  
 
One way this nano architecture may affect cells functionality is by promoting the activation 
of signaling pathways by forcing cellular conformation which may open channels and alter 
adhesion, proliferation, and differentiation as seen in Figure 1.4.2. These pathways mirror 
healthy tissue, promoting positive tissue-surface integration and preventing unfavorable immune 
response or implant rejection.  Other than the nanomeric structures, the surfaces can be 
functionalized with or growth factors to increase cellular interactions 67, 75-78. 
 19 
 
Figure 1.4.2: Image showing how nanoscale formations can affect cell function. Reprinted by 
permission from Macmillian Publishers Ltd: [Nature Reviews Molecular Cell Biology] (Local 
force and geometry sensing regulate cell functions) copyright (2006) 79. 
 
 
1.5 Nanotechnology in Neuroscience 
 
Nano materials have been explored for a variety of neuroscience applications in the 
peripheral and central nervous system 80. Nano engineered materials have been used to promote 
neuronal adhesion and growth as coating for recording or stimulating electrodes in part to limit 
and reverse neuropathological disease 80. These surfaces provide subcellular stimuli that can vary 
across the neuron and have been suggested to coat chronic electrode implants in order limit 
immune response including that of the glial responses. Neurons cultured on nano scaled surfaces 
have been shown to prefer sizes ranging from 10 to 70nm where they demonstrate normal 
morphologies and metabolic activity 80. By providing signals to neural cells by altering their 
interaction with the surface, nano topography may be able to limit reactive gliosis and promote 
direct neuronal adhesion providing more effective and longer lasting neural prostheses.  
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Figure 1.5.1: Nanomaterials and nanodevices that can interact with neural cells to influence 
cellular interaction including engineered materials with nanoscale physical features that produce 
ultrastructural morphological changes. Reprinted by permission from Macmillian Publishers Ltd: 
[Nature Reviews Neuroscience] (Neuroscience nanotechnology: progress, opportunities and 
challenges) copyright (2006) 80.   
 
Until 2006 all neural prostheses, including retinal prosthesis, explored only micron-scale 
features. Features on this scale do not interact with neural tissue at the same molecular level as 
nanomeric features providing different cues, and may prove a disadvantage 80. 
 
Figure 1.5.2: Soma and axon orientation and morphology based on topography shown at 
different magnifications. Surface types include 2!m parallel grooves (A&B), 2!m cylindrical 
holes (C&D), 300 nm parallel grooves (E-H), 300nm cylindrical holes (I&J), and smooth 
surfaces( K&L). Reproduced by permission of IOP Publishing. All Rights Reserved: 
[Biofabrication Vol 2, Issue 3] (Hippocampal neurons respond uniquely to topographies of 
various sizes and shapes) copyright (2010) 81.   
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Submicron patterning has also been shown to increase neuronal growth and dictate 
directional growth 82. More recent explorations have included nano topographies. With 
nanoporous topographies having been shown to increase neuron formation among neural cells 
while greatly reducing reactive astrocyte build up 83. Nanofibers have been show to promote 
neuronal extensions of neural progenitors cells 84. Several studies have reported enhanced 
functionality of neuronal cells on nanofiber 85 and nanowire 86 arrays as well as nanoporous 
scaffolds 83.  
 
1.6 Titanium as a Biomaterial 
 
Titanium and its alloys are one of the most attractive materials for biomedical 
applications, being used in everything from joint replacement and fracture fixation to cardiac 
valves and artificial hearts 87-89. Some titanium alloys have cytotoxic effects due to elemental 
release of alloy components, however commercially pure titanium is considered to be an ideal 
biocompatible metallic material as a result of its surface properties along with its stable and inert 
oxide layer 87, 90-92. This inert layer is crucial as it minimized the release of metal ions which 
could lead to adverse biological reactions as well as mechanical failure of a prosthesis 93. While 
commercially pure titanium does display better biocompatibility and tissue integration than 
stainless steel, its comparative strength and wear resistance limit its applications to low-stress 
low-wear uses compared to other forms of its alloys. Although titanium has favorable 
biocompatibility, chronic implantation of any biomaterial may still result in physiological 
reactions such as inflammation, infection and, of particular interest in neural applications, 
fibrosis 89, 94-96. Physiological responses to the biomaterial such as fibrosis may inhibit the 
usefulness of the implant such as electrical conduction in neural implants. This scarring is a 
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result of insufficient biocompatibility leading to the neutralization or isolation of the implant 
from the natural tissue it was in contact with 97.  
It has been shown that cells prefer to grow and differentiate on electronically charged 
surfaces 98, correlating directly to the operation of neural implants 99. However as implant 
miniaturization is desirable to reduce the amount of disturbed tissue 48 the thin-film materials 
used in the implants, including titanium alloys, begin to have serious limitations. Electrode 
impedance scales inversely with electrochemical interface capacity or surface area 99. Thus to 
continue to use common thin films in these applications, nano topographic structures are 
necessary to increase surface area and maintain sufficient recording sensitivity 99. While previous 
research has been done using the electrically conducting polymer polypyrrole in neural implants, 
it degrades when placed under continuous electrical stimulation 86, 100-101. Highly crystalline 
structures, such as those produced by annealing titanium nanotube arrays formed by the 
electrochemical anodization process, provides a direct and rapid transport pathway and increases 
electrical conductance. This property allows crystalline titania nanotube arrays to be considered 
semiconductors 102. A study on the electrical properties of a single titania nanotube has shown 
their resistivity is similar to semiconductors such as silicon. Upon annealing the resistance of the 
titania nanotube drops even more as the anatase phase increase forms an even shorter electrical 
pathway 103. This semi conductive property as well as topography of titania nanotube arrays 
satisfy the important electrical characteristic necessary for a neural implant.  
 
1.7 Nano-Scale Surface Modifications on Titania 
 
Many methods have been developed to produce nano topographic surfaces of titanium and its 
alloys. Some of these methods include sol-gel, micelle and inverse micelle, hydrothermal and 
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solvothermal, electrochemical anodization, chemical and physical vapor deposition, 
electrodeposition, as well as sonochemical and microwave processing 104. Varying techniques 
and their conditions have been used to develop nano architectures of particles, rods, tubes, 
dendrites 105, wires, belts 106, flower-like 107-109, and amyloid-like 110 structures. Titania nanotube 
arrays have become forerunner topographies for biomedical device interfaces due in part to their 
manufacturability, ability to induce cellular activity, capacity of controlled drug delivery 111, and 
their ease of incorporation onto existing implantable devices. Titania nanotube arrays have been 
formed using hydrothermal as well as electrochemical anodization and microwave processes to 
produce vertically oriented, freestanding arrays, with nanotubes of high aspect ratios 104, 112-113. 
Alloys with these nanoscale surface modifications have proven biocompatibility and notable 
mechanical, optical, and electrical properties 118-119. These properties as well as their extremely 
high surface areas make them of great interest for studies in biomedical 114-116, sensing 117-118, and 
photovoltaic applications 110, 119-123.  
 
1.8 Using Neural Stem Cells as a Model for Neural Prostheses Research 
 
The development of new neural cells or neurogenesis is understood to discontinue soon after 
birth 124-125. Neurogenesis may produce a variety of primary cells including neurons, astrocytes, 
microglia, and oligodendrocytes or Schwann cells 126. While these primary cells can be used 
ensuring the carry over of the complexity of the nervous system, they require mammalian donors 
that lead to high costs and extended study lengths. Therefore, efforts have been directed toward 
developing alternative models through the use of neural stem cells. It was found that neuronal 
precursor cells could be obtained from the central nervous system of an adult and induced into 
differentiation 125 producing neurons and astrocytes 124. These neural stem cells (NSCs) allow for 
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rapid and inexpensive modeling of neurobiological systems, and limit the specificity of neural 
phenotype necessary when selecting primary neural cells. 
Many NSCs have been previously explored and show different levels of differentiation 
and lineages 127. Multipotent progenitors cells have the potential to be used in the study of how 
biochemical and molecular genetic approaches affect the mechanism and commitment decision 
during late periods of neurogenesis or new neuron formation. The C17 line shows multipotency 
expressing oligodendrocyte and neuronal markers sequentially 127. Original cultures of cerebellar 
line C17 were composed of large bipolar cells with prominent nuclei among smaller bipolar 
cells, as well as flat and broad cells. Early work done with this cell line cultured from a frozen 
vial showed altered protein markers as a function of culture time. Cell morphologies 
transformed, beginning with flat morphologies and expressing markers for oligodendroglial then 
within several weeks became more bipolar, expressing markers consistent with neuronal 
phenotypes 127. Subclones of the C17 line also expressed the differentiation marker for astrocytes 
128. One specific subclone, C17.2, was derived after v-myc transfection of neural stem cells 
isolated from the germinal layer of a neonatal mouse cerebellar cortex as seen in Figure 1.8.1 129-
130. Preliminary studies of this subclone were performed in cocultures with primary cells from 
mouse cerebellum. In coculture this clone was shown halt proliferation and undergo drastic 
morphological changes, becoming compact with long bipolar and occasionally multipolar 
processes. When cultured alone, the subclone showed mainly large, flat, epithelial-like structures 
128. The C17.2 line has become increasingly popular due to its developmental potential similar to 
endogenous neural progenitor stem cells as they are multipotent, and with the aid of 
differentiation media and supplements the cells can transform into all neural cell types without a 
primary cell coculture 129-130. 
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Figure 1.8.1: Immortalized cerebellar precursor cells for neurological repair. Reprinted by 
permission from Macmillian Publishers Ltd: [Nature Biotechnology] (Neural Stem Cells, 
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CHAPTER 2 
FABRICATION AND CHARACTERIZING OF SUBSTRATE 







Titanium and titanium alloys are the most widely used biomaterials due to their 
mechanical properties and biocompatibility. However they are rarely sought after in neurological 
application due to the formation of an amorphous passive oxide layer on thier surface that while 
enhancing corrosion resistance and providing a mechanically robust surface, reduces its electrical 
conductance. When used in neural prostheses, limiting the size of the implant is critical to avoid 
disturbing tissue outside of the targeted area. With a reduction in size conductance of thin films 
also decrease. By modifying the surface of titanium with the formation of titania nanotubes, both 
of the roadblocks stunting titanium’s use in neural prosthetics can be overcome. The structure of 
the nanotube and a crystalline structure formed through annealing decrease the electron pathway, 
forming a semi conductive material. The scale and topography greatly increase the 
electrochemical surface area further increasing its effective conductance. 
Biomimetic surfaces represent the physiological hierarchy of living tissue at a nanomeric 
scale. This tissue like structure allows for enhanced implant integration that may lessen the 
extent of infection and rejection 1-6. The increased surface area of nano-modified surfaces allows 
for greater area of neural tissue interaction and conduction. In this study titania nanotube arrays 
of two different topographies were fabricated using an electrochemical anodization process with 
different parameters to produce well controlled and reproducible nano architectures 7-9. The 
mechanical and electrical properties of the nanotube arrays were characterized using SEM 
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imaging, GAXRD, four point probe testing, as well as nano indentation. Previous work has been 
done showing the significant impacts nanoscale surface can have with neural tissue 4, 10-15. Tissue 
response may be affected by the incorporation or adsorption of proteins onto the surface of 
neurological prostheses. Therefore an evaluation of key proteins that may be adsorbed during 
implantation of the prosthesis was performed.  The improved electrical and biocompatible 
properties as well as protein interaction of these titania nanotube arrays bring a rise of interest to 
their efficacy as a neural prosthesis interface. 
 
2.2 Fabrication of Experimental Surfaces 
 
2.2.1 Fabrication of Titanium Dioxide Nanotube Arrays 
 
Titanium dioxide or titania (TiO2) nanotube arrays were fabricated using an 
electrochemical process previously described 16. The electrochemical process fixture can be seen 
in Figure 2.2.1 with a fluoride containing electrolytic solution, platinum anode, and titanium 




Figure 2.2.1: Graphical representation of electrochemical anodization fixture. 
 
 
The stages that govern anodic growth of a metal are a balance between anodic oxide 
formation and chemical dissolution of the oxide. However in the presence of fluoride ions the 
situation is much more complex. This is in part due to the formation of a soluble fluoride 
complex and a small ionic radius allowing the complex to enter the growing TiO2 lattice and 
move across the oxide by an applied field 17. The nanotube arrays are thought to occur as a result 
of high fluoride species concentration at the bottom of the nanotubes, with the more soluble TiO2 
between pores, which can be continuously dissolved and deposited in the tubular structure as 




Figure 2.2.2: Nanotube formation using electrochemical anodization. Reprinted from Current 
Opinion in Solid State & Materials Science, Volume 1, Issues 1-2, J.M. Macak, H. Tsuchiya, A. 
Ghicov, K. Yasuda, R. Hahn, S. Bauer, P. Schmuki, TiO2 nanotubes: Self-organized 
electrochemical formation, properties, and applications, page 8, copyright (2007) 17. 
 
 
Two different fluoride containing acidic electrolytic solutions were used to form two 
different nanotube array topographies. An electrolyte composed of 99 volume % deionized water 
with 1 volume % (48%) hydrofluoric acid was used to create densely packed, highly ordered 
highly ordered TiO2 nanotube arrays with coincident walls. An acidic organic fluoride-
containing electrolyte of 95 volume percent (99%) diethylene glycol, 2 volume percent (48%) 
hydrofluoric acid, and 3% deionized water produced loosely packed, highly ordered TiO2 
nanotube arrays. The water-based anodization was run at 20V for 3.5 hours, whereas the 
diethylene glycol based anodization was performed at 60V for 24 hours. All sample types were 
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removed from solution, sprayed with deionized water, and then rinsed in three subsequent 
deionized water baths for 15 seconds per bath by vigorously shaking the sample back and forth 
while holding it with tweezers. The samples were dried with pressurized nitrogen, and then 
annealed. The water-based electrolyte-derived nanotubes were annealed at 530°C for 3 hours at a 
ramp rate of 15°C/min. The diethylene glycol based electrolyte derived nanotubes were annealed 
at 530°C for 5 hours at a ramp rate of 15°C/min. 
 Throughout this paper the following notation will denote the different titanium 
substrates: Ti – Commercially pure (97%) Titanium; NT – H2O – Titanium dioxide nanotubes 
arrays manufactured with deionized water based electrolyte; NT – DEG – Titanium dioxide 
nanotubes manufactured with diethylene glycol based electrolyte.  
 
2.2.2 Fabrication of Polycaprolactone Nanowire Arrays 
 
Polycaprolactone (PCL) nanowire arrays were manufactured using a polymer nano 
extrusion techniques via template synthesis developed in the Biomaterials Surfaces Micro/Nano-
Engineering Laboratory (BSµnEL) 18.  The process is illustrated in Figure 2.2.3. PCL discs of 
8.83 mm diameter and 3 mm thickness were placed on top of a commercially available alumina 
membrane with average pore diameter of 20 nm. The substrate and template were then placed 
into an oven at 115°C until the ceramic/polymer interface became transparent between three and 
five minutes. The extruded samples were removed from the oven, flipped over, and allowed to 
cool before being placed in a 1M sodium hydroxide solution for 75 minutes. The basic solution 




Figure 2.2.3: Process of PCL nanowire formation using template nano extrusion method.  
 
The arrays were then thoroughly rinsed in three subsequent baths of deionized water by 
swirling the sample in the beaker for 30 seconds before replacing the water with fresh deionized 
water. The arrays allowed to air dry and placed in a desiccator until characterization or 
sterilization. The nano architecture was visualized using scanning electron microscopy at various 
magnifications. Henceforth polycaprolactone nanowire arrays will be denoted NW. 
 
2.2.3 Protein Adsorption on Surfaces 
  
 In order to see how proteins that may be present during neurosurgery may affect reactive 
gliosis and neuron adhesion to the implant, fibrinogen, albumin, and laminin adsorption was 
investigated on the multitude of nano architectures. All of the surfaces were sterilized by a 30 
minute 70% ethanol bath, followed by two rinses with a phosphate buffer solution (PBS), then 
by 30 minutes of UV exposure in a class II, Type A2 Biosafety cabinet. The surfaces were then 
incubated in a 100!g/mL solution of each protein under consideration. The incubation was 
carried out at room temperature on a horizontal shaker plate at 100 rpm for two hours. To 
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remove non-absorbed protein the solution was aspirated and the samples rinsed three times with 
PBS. The samples were transferred to fresh 24 wells where the protein was extracted from the 
surface by incubating the samples in a 1% sodium dodecyl sulfate (SDS, Sigma) solution in PBS 
on a horizontal shaker plate at 100 rpm for four hours. The 150µL of the unknown solutions as 
well as standards were then transferred to a 96 well plate. 150µL of working reagent compiled 
from a Pierce Biotechnology micro-BCA Protein assay kit were added to each well. The 
solutions were mixed by on horizontal shaker plate at 100 rpm for 30 seconds. The plate was 
then covered using Parafilm and incubated at 37°C in 5% CO2 for two hours.  After the plate was 
removed and its contents returned to room temperature, the adsorption was measured using a 
BMG Labtech plate reader at 562nm. To remove background absorbance readings for a blank 
were taken and subtracted from the experimental values. Concentrations of the unknown 
solutions were then calculated based on the generated standard curve.  
 
2.2.4 Statistical Analysis 
 
Each experiment was performed on three samples per surface with at least two different 
locations being tested (nmin = 6). The quantitative results were analyzed using the analysis of 
variance (ANOVA) model unpaired Tukey’s post hoc test with statistical significance a p < 0.05. 
The analysis was performed using Minitab. 
 
2.3 Characterization of Surfaces 
 
Nanotube arrays of both morphologies were characterized using a scanning electron 
microscope (SEM, JEOL JSM 6500F), glancing angle x-ray diffraction (GAXRD, Bruker D-8) 
for crystal structure, four point probe conductivity testing, nano indentation to measure the 
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mechanical properties, and surface wettability using a static water-drop method (Rame-hart 




Surface morphology was evaluated using a field emission scanning electron microscope 
(SEM, JEOL JSM 6500F) as seen in Figure 2.3.1 at 15kV for Ti and titania nanotube samples 
and 7 kV for NW samples after sputter coating the samples with 10 nm of gold. Nanotube 
lengths were found by scoring the sample, imaging the delaminated edge. Analysis of the 
morphology provided evidence of reproducible architectures as well as the dimensional 
characterization of the nanotube arrays.  
 
Figure 2.3.1: Colorado State University JEOL JSM SEM 6500F at the Central Instruments 




2.3.2 Crystal Structure 
 
The presence of anatase and rutile crystal phases were identified through glancing angle 
X-ray diffraction (GAXRD, Bruker D8) as seen in Figure 2.3.2 and compared to the naturally 
formed titanium oxide layer on a sample left at ambient conditions for an extended period of 
time. Substrates of 2 cm x 1.5 cm were placed on the test bed while the machine was in its home 
position and held in place using double sided adhesive. An initial scan was performed to find the 
height of the sample by measuring the radiation hits per second as the scanner moved from 
below to above the surface. The height is taken at half of the maximum intensity. A detector scan 
was run at low resolution with theta at zero until the first major crystal peak was detected in 
order to determine two theta. This process was reiterated from a theta of zero to a theta of three 
in increments of half a degree. Two-theta values were chosen when a significant rise in intensity 
was detected. Once the run conditions were determined, a detector scan was run in the range of 
interest at a step side of 0.01 with a time per step of one second. The GAXRD data was then 
analyzed using Diffract.EVA software where the peaks were filtered by material to known 
diffraction patterns of the materials crystal structures. The data was further saved as a text file 




Figure 2.3.2: Colorado State University Bruker D8 XRD (Glancing Angle attachment not 





Conductivity measurements were performed after etching away an area of the nanotube 
array thin film with a solution of hydrochloric and hydrofluoric acid. A mask was applied 
between the two surfaces before being sputter coated with 40nm of gold to create ohmic 
contacts. The mask was removed along with any coating on the sides and back of the sample 
providing a partition between the bulk titanium and titania nanotube contacts. A four-point probe 
arrangement was placed onto the surface of the sample with a voltage source probe and a current 
measuring probe on the etched Ti and titania nanotube arrays an illustration of this system can be 
seen in Figure 2.3.3. A voltage was applied across the sample, and current was measured 
producing a JV curve, the device used can be seen in Figure 2.3.4. The resistivity of the 
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nanotube arrays and bulk Ti and NW were calculated. Calculation of resistivity allowed a 








Figure 2.3.4: Four-point probe conductivity test fixture on gold coated Ti sample at the 
Colorado State University Materials Engineering Laboratory.  
 
 
2.3.4 Mechanical Testing 
 
The mechanical properties of the titanium dioxide nanotube arrays where characterized 
using nano indentation with a Nano Indenter XP seen in Figure 2.3.5. Two testing parameters 
were used. The first test parameter consisted of 1 load-unload cycle. The second parameter 
consisted of 6 loading cycles within a maximum load of using two different indentation tips. A 
spherical tip and a Berkovich (3-sided pyramid) were used. The spherical tip allows for a better 
representation of elastic modulus while the Berkovich tips gives a better representation of 
hardness. Three samples were tested per morphology with 16 indentations per sample. Nano 
indentation allows for the characterization of the material stiffness with regards to its nano 
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architecture, and not just the bulk material properties. This measurement allows for the 
characterization of the material properties at cellular level interaction. 
 
Figure 2.3.5: Nano indenter XP (MTS) at Pontifical Catholic University of Paraná, Curtiba 
Paraná, Brazil holding each sample type. Image courtesy of Paulo Soares Jr.  
 
 
2.3.5 Wettability and Surface Energy 
Surface wettability or hydrophilicity was conducted using the static water drop method on 
each nanotube array morphology, Ti and NW arrays. Deionized water was contained in a syringe 
with a controllable volume discharge as seen in Figure 2.3.6. Images were captured immediately 
after water droplet release. The contact angle goniometer was used to find the angle of phase 
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separation between the liquid-solid, and liquid-vapor interface. The degree of separation 
indicated the hydrophilicity/hydrophobicity with contact angle less than 90° being considered 
hydrophilic, and contact angles greater than 90° being considered hydrophobic as displayed in 
Figure 2.3.7. Contact angles were then used to calculate surface energy 19 where more 
hydrophilic surfaces correlate to higher surface energies. Characterizing the hydrophobicity and 
surface energy of the surfaces provides insight into the protein and cellular thermodynamic 
interaction with the surface. 
 






Figure 2.3.7: Illustration of surface wettability exhibiting hydrophobic and hydrophilic 
characteristics.   
 
2.4 Results and Discussion 
 
An electrochemical anodization process forms titania nanotube arrays where the 
dissolution of titanium in the fluoride containing electrolyte solution competes with its 
deposition back onto the bulk substrate 17. This process is demonstrated in Figure 2.2.2. A basic 
illustration of the growth of nanotube arrays can be seen in Error! Reference source not found..  
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Figure 2.4.1: An illustration of nanotube array development based on an electrochemical 
anodization process with titanium substrate and oxide barrier layer. Reprinted from Solar Energy 
Materials and Solar Cells, Volume 90, Issues 14, Gopal K. Mor, Oomman K. Varghese, Maggie 
Paulose, Karthik Shankar, Craig A. Grimes, A review on highly ordered, vertically oriented TiO2 
nanotube arrays: Fabrication, material properties, and solar energy applications, page 2028, 
copyright (2006) 20. 
  
Using this technique the nanotube array dimensions (diameter, wall thickness, length) can 
be adjusted by altering the anodization parameters such as voltage 21, electrolyte solution and pH 
22, as well as duration of anodization. Varying these parameters have provided titania nanotube 
arrays ranging from nm to !m in length, 10’s to 100’s of nanometers in diameter and anywhere 
from 9 to 34nm in wall thickness 20-21, 23. After anodization the samples must be annealed to lock 
in their structure 24. The annealing process changes the grain structure of the amorphous titania 
nanotube arrays subsequently stabilizing them. Three crystal structures are know to form 
brookite, anatase and rutile titania 25. The amount of each crystalline structure can be controlled 
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by the annealing parameters such a temperature and ambient gas 26. As temperatures above 
580°C are reached, the larger rutile crystal structure becomes prominent, reforming the grains to 
the point of nanotube destruction as seen in Figure 2.4.2. Each of these variations affects the 
mechanical properties of the titania nanotube arrays, and therefore each unique structure must be 
tested for their efficacy in biomedical applications. Despite the differences in topography and 
crystal structures created by the manufacturing parameters, the properties among sample type 
were found to be uniform and repeatable, and stable enough to be considered for non-
biodegradable biomedical applications.  
 
 
Figure 2.4.2: Breakdown of nanotube architecture due to crystal grain structure reorganization 
at range of annealing temperatures. Amorphous nanotubes annealed at a) 580˚C, b) 680˚C, c) 
880˚C. The rutile crystal structure is seen forming causing the nanotube breakdown as 
temperature increases. Reprinted from Cambrudge University Press, Journal of Materials 
Research, Volume 18, Issues 1, Oomman K. Varghese, Dawel Gong, Maggie Paulose, Craig A. 
Grimes, Elizabeth C. Dickey, Crystallization and high-temperature structural stability of titanium 
oxide nanotube arrays, page 159, copyright (2003) 26. 
  
For this research two topographies of titania nanotube arrays created using the 
anodization technique were studied. Each topography was built upon the same commercially 
pure titanium whose microscopic scale can be seen in the scanning electron micrograph of 
Figure 2.4.3 where the highlighted portion is magnified in the image on the right.  
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Figure 2.4.3: Electron micrograph of commercially pure titanium. 
 
 
The structures resulting from each method were examined for uniformity and 
repeatability. The NT – H2O protocol discussed in Section 2.2.1 produced samples that exhibited 
a spectrum ranging from brown to emerald green after annealing, with sporadic purples 
speckling. If the process was carried out in a once used, or ‘conditioned’ electrolyte solution, the 
spectrum appeared more uniform across the entire samples absent of any purple speckling. This 
protocol produced nanotube arrays that were highly ordered, with coincident walls ranging from 
75 – 105 nm in diameter with wall thicknesses of approximately 15-25 nm and lengths around 
1.25!m as seen in Figure 2.4.4. The walls of these nanotubes appeared rough and uneven. There 
was little height variance across the surface of the sample. Extensive force was necessary to 
detach these nanotube arrays from the underlying titanium to obtain their length. After scratching 
and bending of the surface to expose the side of the nanotube array, they were measured using 
SEM to be 1.25!m. To stabilize the nanotube arrays they were annealed in ambient air at 530°C 






Figure 2.4.4: Electron micrograph of NT – H2O including cross sectional view of length. 
 
The second manufacturing protocol was for the NT – DEG and was performed as 
discussed in Section 2.2.1. This nano architecture produced a spectrum from blue to purple after 
anodization, which became tinted white after annealing. These samples were not as well adhered 
to the substrate, and would occasionally delaminate from the bulk material while rinsing or peel 
at the anodization boundary after annealing. Although surface uniformity increased with 
‘conditioned’ or once used electrolyte, delamination also increased. SEM images show 
individual nanotubes that would cluster together forming anemone like structures. These 
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nanotubes had diameter ranging from 105-145nm with wall thickness varying greatly along their 
length mainly between 13-23nm, though vacancies could be seen in some areas as shown in the 
high magnification image of Figure 2.4.5. Lengths were measured at delamination sites, ranging 
from 3.5-4.0!m. The microscopic surface reflected the macro scale surface features as peaks and 





Figure 2.4.5: Electron micrograph of NT – DEG including cross sectional view of length. 
  
The differences in annealing times and formations of NT – H2O and NT – DEG as well 
as Ti lead to differences in crystalline phases that were identified by XRD. Figure 2.4.6 shows 
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the stacked results of the XRD analysis that indicate increasing anatase and rutile structures in 
the nanotube arrays as compared to the bulk substrate. The NT – DEG samples shows a more 
pronounced presence of anatase phase where as the NT – H2O samples show a higher presence 
of rutile crystal structure and the amorphous titanium dioxide structures.  
 
Figure 2.4.6: XRD spectra of Ti, NT – H2O and NT – DEG showing amorphous, anatase and 
rutile crystal structure. 
 
The presence of amorphous and rutile crystal structures correlate to lower conductivity as 
the electron free path length is greater than in the anatase phase. This difference in crystal 
structure in part explains the differences in conductance of each sample type when tested using 
the semiconductor standard four point probe test. To test the thin film conductivity of the 
nanotube arrays samples, half of the nanotube arrayed area was etched away to bare titanium, 
and a contact partition masked before 40nm of gold was sputtered onto each side. Current was 
 58 
forced across the thin film with voltage measured. The comparison of the materials 
conductivities can be seen in Figure 2.4.7.  
 
 
Figure 2.4.7: Thin film conductivity in Siemens per meter measured using a four-point probe 
conductivity test with the NW surfaces being significantly less conductive than any of the 
titanium or titania surfaces (!, p < 0.05) and the NT – DEG surfaces being significantly more 
conductive than the NT – H2O surfaces (#, p < 0.05) 
  
NW arrays were fabricated via template nano extrusion as described in Section 2.2.2. 
After removing the alumina membrane, rinsing and drying the samples, they were examined by 
scanning electron microscopy. The surfaces were homogenous containing vertically orientated 
nanowires that bundle together forming islands and fissures as seen in Figure 2.4.8. This 
formation is thought to form as a result of static surface interactions between the individual 
nanowires during the dissolution of the membrane. The nanowires also expand during the 
membrane removal process to around 200nm in diameter or 10 times their extrusion diameter. 
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Variations in extrusion temperatures and rates were seen to cause large variations in morphology, 
including large non-extruded regions. If the extrusion was run for an extended period of time, the 
nanowires were seen to pass through the membrane, becoming blunted by the glass surface 
holding the sample and membrane.   
 
 
Figure 2.4.8: Electron micrograph of NW array formed via nano template extrusion using a 
20nm alumina membrane. 
  
Biomaterial surface energy is of high importance to its functionality as biological 
components bind to the surface.  Surface energy has been directly correlated to the wettability of 
the surface 19 allowing it to be measured using a goniometer. The biological components display 
varying levels of interaction with hydrophobic and hydrophilic surfaces, and thus the surface 
wettability can direct cell adhesion and cellular function. Studies have shown that cellular 
adhesion is favored on hydrophilic surfaces 27-28 that are indicative of the extracellular space 
allowing proteins to remain in their natural conformation. All sample material surfaces were 
tested using the goniometer by placing a small droplet of water on the surface of the sample, and 
measuring the angle between the solid-liquid and liquid-vapor boundary, also known as contact 
angle. Contact angle decreased along with the scale of the surface. NT – DEG samples had the 
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lowest contact angle and thus highest surface energy, as the clusters of nanotubes are thought to 
wick more water into the nanotube arrays.  
 
 
Figure 2.4.9: Surface energy calculated based on contact angle in accordance with Equation 
2.4-1. Ti and NW surfaces had significantly lower surface energy than the nanotube array 
surfaces (# , p < 0.05). 
 
Figure 2.4.9 indicates the contact angle and its correlating surface energy for each 
sample type. The error on the surface energy is not symmetric as the relation between contact 
angle and surface energy is driven by a cosine function as shown in Equation 2.4-1 19. Where Es 
is the surface energy and Elv is the energy coefficient at the liquid vapor interface at 72.8mJ/m2 at 
20°C for pure water. The static contact angle is designated by ".  
 




Representative images of each surface are seen in Figure 2.4.10. Flat PCL discs were not 
evaluated but were previously studied and found to have a contact angle of 77.81 ± 0.89° 8 which 
is larger than Ti and thus would have a surface energy below 47.9 mJ/m2. It should be noted that 
the NT – DEG samples were extremely wettable and the droplet would disperse and evaporate in 
a short amount of time.  
 
 
Figure 2.4.10: Goniometer testing of liquid-vapor-solid interface using water on all surfaces. 
 
During the process of implantation, these prostheses are exposed to proteins from the 
blood when breaking through the blood brain barrier, as well as proteins that are present in the 
neural tissue. These proteins adsorb onto the surface of the implant rapidly 29 and can greatly 
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impact the prosthesis interaction with the surrounding tissue 30-36. The proteins of albumin, 
fibrinogen, and laminin are a few of many that may come in contact with the prosthesis during 
implantation, and have been shown to greatly affect how neural tissue respond, and thus their 
absorption is important to investigate 30-32, 34-35, 37. Fibrinogen has been shown to increase 
immunoreactivity, expressed through the reactive astrocyte marker, glial fibrillary acidic protein, 
which can increase scar tissue formation around the implant and decrease the prostheses 
longevity 34. Albumin has been implicated in Alzheimer’s disease as it can bind to and transport 
the amyloid beta protein, which is a causative agent in Alzheimer’s disease 30. Laminin has been 
found to promote neuronal adhesion onto surfaces without the aid of glial cells, as well as 
yielding more extensive neurite outgrowth 32. Therefore, the design of a material surface that 
could promote the beneficial protein adhesion or adsorption of laminin while minimizing the 
binding or adsorption of the detrimental albumin and fibrinogen would be ideal for neurological 
prostheses.  
To observe how the surfaces interact with these proteins, the proteins were adsorbed at a 
concentration of 100µg/mL for two hours before the adsorbed proteins were detached using the 
anionic detergent SDS, collected and their concentration measured using a micro-BCA assay. 
The highly specific chromogenic reagent bicinchoninic acid (BCA) forms a complex with the 
copper I molecule by protein reduction in an alkaline environment. The amount of Copper I 
complex present correlates to the concentration of the protein in solution as well as the 
incubation time in BCA. The absorbance of the unknown solution can be measured and 
compared to a curve based on the absorbance for known concentrations of protein. The linear 




Figure 2.4.11: Relative amounts of proteins that may be exposed to neural prostheses adsorbed 
on control Ti, NW arrays, NT – H2O arrays, and NT – DEG arrays as determined using a micro-
BCA assay. Significantly higher amounts of laminin adsorbed onto NT – DEG surfaces, will 
significantly less being adsorbed onto the NW surfaces. (!, "# p<0.05). 
  
There was no significant difference among the surfaces for the negatively influential 
blood serum proteins of albumin and fibrinogen. However, a significant difference was seen 
among the surfaces for the beneficial scaffold protein laminin. The amount of laminin adsorbed 
onto the NT – DEG arrays were significantly higher than the amount adsorbed onto the NW 
arrays (p < 0.05). 
The modulus and hardness of the surfaces due to their nano architecture were 
characterized using a Nano indenter XP (MTS). Analysis was carried out with a spherical tip 
with 100 micron radius for modulus and a Berkovich (3-sided pyramid for hardness both with 
area function calibrated using fused silica. Two test parameters were used; the first method was a 
single load-unload cycle with a maximum applied load of 0.1gf (1mN). The second test 
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parameter consisted of 6 loading cycles within the maximum load of 5gf (50mN), at 2.5, 1.25, 
0.625, 0.3125, 0.125gf for each tip with holding times of 30 seconds. The modulus and harness 
were determined by the Oliver and Pharr method 38.  
 
Figure 2.4.12: Titanium and titania hardness tested using a Berkovich tip with one load/unload 
cycle at 1mN.  
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Figure 2.4.13: Titanium and titania nanotube array hardness tested using a Berkovich tip at six 
loads with 30 seconds cycles.  
 
  
After testing was performed the locations of indentation were visualized using SEM. The 
compaction of the nanotube arrays in the NT – DEG samples is apparent in Figure 2.4.14. The 
impressions produced through nano indentation on the NT – H2O samples were not readily seen 
using SEM and are thus absent.  
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Figure 2.4.14: Scanning electron micrograph showing nano indentation of NT – DEG sample 
with Berkovich tip.  
 
 
 The hardness measured with both parameters using the Berkovich tip shows a 
significantly lower hardness for the NT – DEG arrays than the NT – H2O arrays and Ti. The high 
displacement of these NT – DEG arrays shows that they deform greatly before compacting 
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enough to show any resistance due to their anemone-like structure. The NT – H2O arrays are 
very comparable to titanium once they have been displaced just a little due to their dense 
packing. The elastic moduli of both nano architecture surfaces were significantly lower than that 
of the titanium, as can be seen in Figure 2.4.15. The NT – DEG array show a much higher 
displacement before reaching the moduli of the NT – H2O and Ti surfaces, once again indicating 
that the NT – DEG surfaces deform and compact. Scratch testing was also performed to measure 
the delamination force, as seen in Figure 2.4.17 and Figure 2.4.18.  
 
Figure 2.4.15: Elastic moduli of Ti and titania nanotube arrays measured at 1mN with a spherical 




Figure 2.4.16: Elastic moduli for Ti and titania nanotube arrays measured at six loads for 




Figure 2.4.17: Scratch test of NT-DEG sample using a spherical tip with a radius of 100 










The surface properties of any implantable biomaterial are the first and main interface 
with biological tissue and as a result their properties are of the utmost importance. How the cells 
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of the target tissue respond depend on the size, structural and chemical properties of the material. 
The size and structure of the surface can induce cellular response based on their stiffness and 
topography by forcing the cells into different shapes affecting how and what can attach to the 
surface. The material wear and corrosive resistance affect the cytotoxicity of the material as ions 
released from the surface of the implant are seen as foreign bodies and result in an immune 
response 39-47. Therefore the properties of the surface are essential to the long term in vivo 
response to any implantable device. To identify the capabilities of titania nanotube arrays as 
interfaces for neural tissue applications, this research has investigated the characteristics of two 
topographies of titania nanotube arrays in comparison with the Ti and previously studied NW 
arrays. The properties of interest include the nano architecture, material crystal structure, 
electrical conductivity, surface wettability, and material hardness. Testing was performed using 
SEM, GAXRD, four-point probe, goniometer, and nano indentation.  
Titania nanotube arrays were fabricated using two solutions, a water based and a diethylene 
glycol based fluoride containing electrolytes in an electrochemical anodization process. The 
water-based process was carried out at 20V for 3.5 hours followed by thorough water rinsing and 
annealing at 530°C or 3 hours ramped at 15°C/min. The diethylene glycol based process was 
carried out at 60V for 24 hours followed by thorough water rinsing and annealing at 530°C for 5 
hours at a 15°C/min ramp rate. Analysis using SEM indicates very different nano architectures. 
The former showed uniform surfaces of coincident nanotubes with diameters from 75-105nm, 
wall thickness around 15-25 nm and lengths of approximately 1.25µm. The later produced 
vertically orientated nanotubes that were more separated and would bundle together to form an 
anemone like structure. Tube diameters range from 105-145nm, wall thickness from 13-23nm 
and lengths up to 4.0µm. NW arrays were manufactured by template nano extrusion through a 
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0.02µm alumina membrane that was subsequently dissolved in a sodium hydroxide bath for 75 
minutes. The nanowire arrays were then rinsed thoroughly and dried in a desiccator. The 
nanotube arrays were seen to have two different crystalline compositions, and significantly 
different conductance. NT – DEG samples were seen to contain a larger percentage of the 
anatase phase, and were also more electrically conductive, comparable to silicon semiconductors, 
these more conductive surfaces make it possible to continue electrical stimulation in neural 
prostheses. NT - DEG surfaces also provided the most hydrophilic surface compared to the Ti 
control, NW arrays or NT – H2O samples. Nano indentation testing indicated softer nano 
architectures for the NT-DEG arrays which corresponds to the hardness of neural tissue. These 
properties combine to identify titania nanotube arrays, especially those of the NT – DEG 
topography to be promising interfaces for neural prostheses. The results indicate that more 
conductive material with a random and hierarchical architecture may increase favorable protein 
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 CHAPTER 3 
EVALUATION OF THE EFFECT OF TITANIA NANOTUBE ARRAY 
TOPOGRAPHY ON THE ADHESION, PROLIFERATION, VIABILITY, 
CYTOSKELETAL ORGANIZATION, AND MORPHOLOGY OF MURINE 






To combat a variety of neural disabilities, implantable neurological prostheses are being 
used to signal, stimulate, and record neural activity 1-15. Trauma induced by the process of 
implantation as well as the foreign body response to the implant itself have led to poor tissue 
integration and device longevity as glial scar encapsulation of the device limits signal 
transduction. Previous work has been done indicating topographies of various scales can promote 
various neuron morphologies especially in controlling axon directionality. However, a minimal 
amount of this work has been directed towards using nano topographies to limit reactive gliosis 
and promote neuron adhesion and integration for direct electrical stimulation. In this study, 
titania nanotube arrays of two different topographies were analyzed for their potential application 
as interfaces for neural prosthesis. 
Adhesion and proliferation of the stem-like cell subclone C17.2 were studied using 
fluorescence microscopy of the cell nucleus analyzed using imageJ software. This study 
measures if the nano architecture surfaces enhance direct neuron adhesion or the attachment of 
stem cell for neurogenesis. Cell viability studied through mitochondrial activity indicates if the 
changes in surface nano architecture affect cytotoxicity. Cytoskeletal arrangement and cell 
morphology studied through fluorescence microscopy and scanning electron microscopy provide 
a mean of analyzing cellular interaction with the nano architectures and whether these 
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interactions may lead to direct neuronal adhesion and interaction, or glial encapsulation of an 
implant with this surface modification.   
 
3.2 Experimental Methods 
 
3.2.1 Fabrication and Characterization of Nano topographic surfaces 
 
NW arrays and two topographies of titania nanotube arrays were fabricated as described 
in Chapter 2 16-17. In short PCL discs were extruded through alumina nanoporous membranes that 
were then dissolved in sodium hydroxide leaving nanowire arrays protruding from the bulk 
substrate. Titania nanotube arrays were manufactured using an electrochemical anodization 
technique on pure titanium in a fluoride-containing electrolyte; the samples were then rinsed and 
annealed to produce crystalline titania nanotube arrays of different topographies and crystal 
structures that were adhered to the bulk titanium substrate.  
 
3.2.2 C17.2 Cell Culture 
 
Multipotent murine neural stem cell (mNSC) subclone C17.2 were generously provided 
by Evan Y. Snyder, M.D., Ph.D. These cells were isolated from the external germinal layer of a 
male neonatal mouse cerebellum and further modified by avian myelocytomatosis viral-related 
oncogene (v-myc) transfection 18. This cell clone has been extensively used and characterized 
indicating their accuracy in representing the mammalian central nervous system. Cells below 
passage 3 were used in all experiments. The medium the cells were grown in contained the 
following: 
• High Modified Dulbecco’s Modified Eagle’s Medium (DMEM) 
o  Glucose (4500mg/L) 
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o L-glutamine 
o Sodium Pyruvate 
• 10% Fetal Bovine Serum (FBS) 
• 5% Horse Serum (HS) 
• 1% L-glutamine (2mM) 
• 1% Penicillin /Streptomycin/Fungazone combination 
 
The contents of a 1mL frozen vial of cells were split among two Greiner bio-one 
CELLSTAR™ 100mm x 20mm vented tissue culture polystyrene petri dishes that had been pre-
filled with 3 mL of media. Thawed cells were gently pipetted between the two pre filled petri 
dishes alternating between dishes after each drop. The vial was rinsed twice with 1mL of fresh 
media, and distributed between the culture dishes similarly. The culture dishes with cells were 
incubated at 37C at 5% CO2 for eight hours. Media was aspirated after eight hours and replaced 
with 10 mL of fresh media in each dish. The cells were allowed to reach confluence, which 
occurred around three days if culture. Once confluence had been reached, the cells were sub 
cultured by trypsinization. The cells were rinsed twice with 5mL of PBS before adding trypsin 
(0.05%) and incubating for five minutes at 37°C and 5% CO2. After incubation, 3 mL of media 
was added to each culture dish to deactivate the trypsin. The cells were gently triturated 15 times 
to ensure complete deactivation. Interaction of air was carefully avoided while mixing. The cells 
were split at 1:10 into two new sub-culture dishes per culture by pipetting 1mL between two 
culture dishes pre filled with 10 mL of media. The subcultures were incubated at 37°C at 5% 
CO2 until a cell coverage of about 70% was reached before seeding onto the surfaces. 
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3.2.3 C17.2 Cell Culture on Surfaces 
 
Sample types were sterilized prior to seeding by incubating in 70% ethanol for 30 
minutes, two subsequent washes with PBS were performed and the samples allowed to air dry, 
followed by a 30 minute UV exposure in a Class II, Type A2 biosafety cabinet. To seed cells, 
media was aspirated out of the petri dish and the cell subculture rinsed twice with 10 mL of PBS 
before adding 2 mL of 0.05% trypsin to each dish. The cells were incubated at 37°C in a 5% CO2 
incubator for 5 minutes in trypsin. Trypsin was deactivated by adding 3 mL of fresh media, and 
triturating, being careful not to introduce any air. The cell suspension was then placed into 15 
mL centrifuge tubes and centrifuged for one minute at 1000 rpm. The supernatant was aspirated 
and the cells were then rinsed in the centrifuge tubes with 10 mL of PBS and triturated until the 
cells were well dispersed with no aggregates. The suspension was then centrifuged again 
followed by aspiration of the supernatant. The cells were then suspended in PBS and were 
triturated until no aggregates were visible. Concentrations were found using a Millipore 
Scepter™ Handheld Automated Cell Counter with a 60µm sensor attachment, and verified using 
trypan blue dye exclusion with a hemocytometer. The cell suspension was centrifuged a final 
time for one minute at 1000 rpm before the cells were suspended in fresh media. A serial dilution 
was performed to reach the desired cell seeding concentration.  Cells were seeded at a 
concentration of 1000, 1500, and 2000 cells/well in Greiner bio-one CELLSTAR® 24 well 
plates on top of 1cm x 1cm square Ti, NT – H2O, NT – DEG. NW samples of 0.884 cm diameter 
were seeded with the same concentration in 48 well plate of the same manufacture. The first 
media change took place between 24-36 hours, followed by subsequent media changes every 
third day. Media changes were performed by the addition of 0.500 mL of fresh media to the 
existing media. If the wells became to full to safely add fresh media, half of the conditioned 
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media was aspirated before fresh media was added. Analyses of the cells were carried out on day 
1,4, and 7. Cell studies included adhesion and proliferation   studies through cell nucleus 
counting, viability testing using an MTT assay, and morphology studies performed through SEM 
imaging of the cells on the surfaces.  
 
3.2.4 Adhesion and Proliferation of C17.2 Cells on Surfaces 
 
 Cellular adhesion and proliferation was evaluated using 4’6-diamidino-2-phenylindole-
dihydrochloride (DAPI, Invitrogen) nucleus stain fluorescence microscope imaging and imageJ 
analysis of fixed cells on days 1, 4, and 7 of cell culture.  
 Prior to staining, unbound cells were removed by aspirating sample-containing media. 
Surfaces then underwent two delicate rinses with PBS. The samples were moved into new wells 
prefilled with 3.7% formaldehyde in PBS to fix adhered cells. Samples were incubated at room 
temperature for 15 minutes before undergoing two five-minute rinses in PBS. The samples were 
once again transferred to new wells prefilled with PBS where they sat for another five minutes 
before being aspirated and incubated in a 1% Triton X in PBS permeabilizing agent for three 
minutes at room temperature. Samples were then rinsed twice with PBS before being moved to 
new wells containing 300nM concentration of DAPI in PBS where they were incubated for five 
minutes at room temperature before being rinsed twice and stored in PBS. The number of cells 
per sample was determined using the DAPI fluorescence images of the nuclei taken using a Zeiss 
fluorescence microscope with a 5x objective and analyzed using ImageJ.  Image area was used to 
normalize cell count.  
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3.2.5 Viability of C17.2 on Surfaces 
 
 Viability of the C17.2 cells was characterized using a Life Technologies™ Vybrant® 
MTT Cell Proliferation Assay Kit. Before conducting the MTT assay, unbound cells were 
removed by aspirating the culture media and carefully rinsing the samples twice with PBS before 
transferring them to new wells. 100µL of fresh culture medium was added to the well along with 
10µL of the 12mM MTT stock solution which was previously reconstituted by adding 1 mL of 
PBS to one 5mg vial of MTT provided in the kit that was then mixed to ensure no particulate 
remained. An empty well was also filled with 100mL of media and 10µL of the 12mM MTT 
solution to provide a negative control. The samples were then incubated at 37°C and 5% CO2 for 
four hours. Following the incubation, 85µL was removed from the wells followed by the 
addition of 50µL of DMSO thoroughly mixed using a micropipette and then incubated under the 
same conditions for 10 minutes. After incubation with DMSO, the solutions were mixed and 
surfaces scraped with micropipette tips to release any formazan crystals. New tips were used for 
each sample, with the solution from each well being transferred to a transparent 96 well plate for 
absorbance readings, assuring no bubble formation. The absorbance of each sample solution and 
control solution were measured at 540nm using a plate reader (BMG Labtech). The net 
absorbance was calculated by subtracting the background of the control absorbance, quantifying 
the viable cell count.  
 
3.2.6 Morphology of C17.2 on Surfaces 
 
 To study the morphology of the cell as well as their interaction with the surface SEM 
imaging was performed. On the specified days of culture, unbound cells were removed by 
aspirating the sample-containing well, followed by two gentle rinses with PBS. The samples 
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were kept in PBS until being transferred to a glass petri dish containing a primary fixative of 3% 
glutaraldehyde (Sigma), 0.1M sodium cacodylate (Polysciences) and 0.1M sucrose (Sigma) 
dissolved in deionized water. Samples were submerged in primary fixative for 45 minutes before 
being transferred to a new glass petri dish containing a buffer solution similar to the fixative but 
without glutaraldehyde. The samples were submerged for 10 minutes in this solution. Following 
the buffer, samples were dehydrated by subsequent baths of increasing ethanol concentration 
(35%, 50%, 70%, and 100%) for 10 minutes per ethanol bath. A final dehydration was 
performed in a bath of hexamethyldisilazane (HMDS, Sigma) for 10 minutes. Samples were 
allowed to air dry before being stored in a desiccator until imaging. Before imaging, surfaces 
were coated with 10 nm of gold, and imaged at 7kV for the NW array surfaces and 15 kV for the 
Ti and titania nanotube arrays.  
 
3.2.7 Cytoskeletal Organization of C17.2 cells on Surfaces 
  
 The same days of culture cells were analyzed for their cytoskeletal organization. 
Aspiration of sample-containing media removed unbound cells, surfaces were then rinsed twice 
with PBS before being transferred to new wells of the same size that were prefilled with a 10µM 
Life Technologies™ CellTracker™ Green CMFDA in PBS that had been reconstituted using 
DMSO. The samples were incubated in this solution at 37°C and 5% CO2 for 45 minutes. The 
samples were then aspirated before fresh culture media was added. The samples were incubated 
for 30 minutes at 37°C in 5% CO2 in fresh media. This incubation was followed by a single rinse 
in PBS before the samples were transferred to new wells that had been prefilled with a 3.7% 
formaldehyde in PBS fixative where they were incubated at atmospheric condition for 15 
minutes. Each sample was then rinsed twice with PBS for five-minutes before being transferred 
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to a new well prefilled with PBS. This PBS was aspirated and replaced with 1% Triton X in PBS 
permeative for 3 minutes. Permeative was aspirated and samples rinsed once with PBS before a 
solution containing 1:200 rhodamine phalloidin in PBS was added. The rhodamine phalloidin 
had been reconstituted in 500µL of methanol. Samples were incubated in this solution at room 
temperature for 20 minutes. After 20 minutes the 300nM of a DAPI working solution was added 
to the rhodamine phalloidin solution and incubated for 5 minutes at room temperature. The 
samples were aspirated and rinsed twice with PBS before being stored in PBS at 20°C until 
imaging using a Zeiss fluorescence microscope using a 49 DAPI BP 585/50 blue filter, 62 HE 
BP 585/35 Red filter, and BP 474/28 green filter.  
 
3.2.8 Statistical Analysis 
 
Each experiment was performed on three samples per surface with at least two different 
cell populations (nmin = 6). The quantitative results were analyzed using the analysis of variance 
(ANOVA) model unpaired Tukey’s post hoc test with statistical significance a p < 0.05. The 
analysis was performed using Minitab. 
 
3.3 Results and Discussion 
 
Chronic neural prostheses are characterized by their continuous contact and interaction 
with the neural tissue itself. The implantation of a device into the live neural tissue has been 
shown to result in glial scar formation, lasting the lifetime of the implant. A favorable surface 
architecture between the device and the neural tissue would prevent the glial scar tissue 
formation, and promote direct neural adhesion, which is critical for the effectiveness and 
longevity of the device. In order to investigate the neuro-cellular interaction with a nano-
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biomaterial surface for use in neural prostheses, C17.2 cell functionality was investigated on two 
topographies of titania nanotube arrays, as well as the commercially pure titanium they were 
derived from as a control, and NW arrays as a comparison to previous neural tissue – 
nanomaterial studies.  Studies were carried out on day 1, 4, and 7 of culture on the surfaces. 
Cellular adhesion, proliferation, and cytoskeletal organization were examined using fluorescence 
microscopy with DAPI nucleus stain, rhodamine labeled F-actin membrane proteins, and FITC 
labeled cytoplasm stain. Viability was studied using a commercially available MTT assay. While 
cell morphology was analyzed through scanning electron microscopy. 
An electrochemical anodization process was used to fabricate titania nanotube arrays, 
with different fluoride containing electrolyte solutions and different electrical parameters 
creating two different topographies. Vertically oriented, high aspect ratio, anemone-like titania 
nanotube arrays were created after a 24 hour anodization at 60V in a diethylene glycol based 
fluoride containing electrolyte as previous explained 19-20. Tightly packed, coincident titania 
nanotube arrays were formed after a 3 hour anodization at 20V in a water based electrolyte as 
previously studied 17, 21-26. Both nano architectures were examined for uniformity and 
repeatability through SEM imaging as seen in Figure 3.3.1. Diameters range from 105-145nm 
and lengths of 3.5-4.0µm for the NT – DEG samples, and diameter of 75-105nm with length of 
approximately 1.25µm for the NT – H2O samples. These titania nanotube arrays provide a 




Figure 3.3.1: Comparison of nano architectures of NT – H2O and NT – DEG arrays.  
  
NW arrays were created using a procedure previously developed 16 and researched for 
neural tissue engineering applications 27-28. These surfaces produced using 20!m alumina 
membranes formed geometry similar to the NT – DEG arrays however nanowire formation 
formed in larger clusters, with no independent nanowires as can be seen in Figure 3.3.2.  
 
Figure 3.3.2: Nano architecture of NW arrays forming large clusters and fissures.   
 
 Cellular adhesion and proliferation were investigated using fluorescence microscopy of 
DAPI stained nuclei after days 1, 4, and 7 in culture. DAPI is fluorescent stain that binds to the 
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specific A-T regions in DNA and can be used as a live or more readily fixed cell stain. The 
images were analyzed using imageJ software to find the cell density. Previous research using 
NW arrays had seeded C17.2 cells at a concentration of 10,000 cells/well in 24 well plates 27. 
This seeding concentration, while adequate for NW arrays, was not translatable to the nanotube 
arrays, as the samples would reach confluence in a very short period of time. Thus ranges of 




Figure 3.3.3: Cell count performed at days 1, 4, and 7 after seeding at a concentration of 1000 
cells/well, 1500 cells/well, and 2000 cells/well. Culture dish polystyrene was used as a positive 
control. ($$, %, " , ! , " , p  < 0.05) 
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The initial seeding concentration of 1000 cells/well was studied using culture dish 
polystyrene as a positive control. At this point in the research NT – DEG arrays were not used as 
there were difficulties in manufacturing. A significant difference (p < 0.05) was seen on day one 
of culture between the nanotube arrays and the bulk titanium substrate. By day four there was no 
significant difference between the Ti or titania nanotube arrays, however the polystyrene had a 
significantly lower cell density than the Ti but still maintained continued proliferation. Seeding 
concentrations of 1500 cell/well provided a significantly higher cell count on days 1 and 4 for the 
Ti surface, with the polystyrene samples expressing expected proliferation behavior. At a seeding 
concentration of 2000 cells/well the only significant difference was a lower cell density on the 
polystyrene at day 4. This higher seeding concentration also caused a delamination of the cellular 
monolayer that formed on the polystyrene, causing a lower than expected cell count on day 7. 
For this reason an initial seed density of 1500 cells/well was used. The frequency of the 
monolayer delamination also lead to a more stringent procedure for rinsing and staining the cells 




Figure 3.3.4: Adhesion and proliferation study with an initial seeding concentration of 1500 
cells/well. Ti, NT – H2O, NT – DEG arrays were placed in a 24 well plate where as the NW 
arrays were placed in a 48 well plate. Standard error bars are within the shapes indicating the 
sample type. 
  
The initial seeding concentration of 1500 cells/well was tested on all of the surfaces. The 
more delicate washing and staining procedure greatly diminished the removal of the monolayer 
and yielded more expected cell density behavior as a function of time. The NW discs were 
circular as compared to the square Ti and titania nanotube array samples, with a greater 
thickness. To compensate for the thickness to area ratio, the NW surfaces were seeded in 48 well 
plates while the Ti and titania nanotube surfaces were seeded in 24 well plates. A significant 
difference was seen between the nanotube arrays and the Ti and NW array. Proliferation trends 
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were similar among the Ti and titania nanotube arrays however proliferation of the NW arrays 
progressed much more slowly as is reiterated in Figure 3.3.5.  
 
 
Figure 3.3.5: Proliferation ratio of cells on four different surfaces.  
  
The viability of the cells after days 1, 4, and 7 of culture was analyzed using a 
commercially available MTT assay kit. The MTT assay kit is a chromogenic indicator involving 
the conversion of a water soluble chemical MTT to the insoluble crystal formazan by 
mitochondrial succinate dehydrogenase. This enzyme is only present in metabolically active 
cells. Formazan is then solubilized in a detergent and the change in optical density of the solution 
based on the concentration of formazan produced can be determined using a plate reader to take 
spectrophotometric measurements.  
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Figure 3.3.6: MTT results indicating significantly lower (*, p < 0.05) mitochondrial activity or 
cell viability of NW at day 1 of culture, with no significant difference among sample types at any 
other day.  
  
These results show an increase in cell viability over the span of the seven-day 
experiment, further verifying the increased proliferation seen using other methods. There was no 
significant difference between sample types over the long term, however the NW arrays showed 
a significantly lower initial cellular viability (*, p < 0.05) which is indicative of a low initial 
adhesion of the cells on this surface. 
Cell morphology was studied after 1, 4, and 7 days in culture through the use of a SEM to 
visualize the C17.2 cellular interaction with the surfaces and can be seen in Figure 3.3.7. 
Cellular interaction can be seen with the topographies of the NW arrays and NT – DEG arrays 
where as a matrix or large flat, oligiodendroglial-like cells formed on the Ti and NT – H2O 
arrays before neuronal cells are adhered. No morphologies indicate cellular differentiation due to 
the surface topographies. Neuronal morphologies are characterized by long bipolar and 
multipolar bodies 29-32. Cytoskeletal arrangement is further analyzed via fluorescence microscopy 
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to observe more direct nano topographical influences on the cellular structures. The differences 
in NW array architectures arise from larger membrane pore size being used as a result of supply 
issues. The size of the nanowires have been seen to have no significant affect on cellular 
interaction 33.   
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Figure 3.3.7: SEM images of each cell type at lower and higher magnifications. Cellular 
extensions can be seen interacting with the nano architectures in the NW arrays and the NT – 
DEG arrays, where as a matrix or large flat cells are seen on the Ti and NT – H2O array samples 
before any other cellular morphology or attachment is seen.   
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 Cellular interaction with surface topographies can direct cytoskeletal reorganization and 
cell morphology. Cytoskeletal components include microfilaments, microtubules, and 
intermediate filaments. These components take part in everything from cell division to protein 
transport 34. The cytoplasm, cytoskeleton, and nucleus were fluorescently stained on day 1, 4, 
and 7 of culture on each of the surfaces as seen in Figure 3.3.9. The results show early spindle 
shape formation on NT – DEG samples, with more activated microglia-like shapes, as depicted 
in Figure 3.3.8 on the NT – H2O samples. Both of which reach confluence by day 7 of culture. 
The Ti samples show cellular spreading with occasional extensions while the NW arrays show 
more spherical cellular structures through the length of the study indicating poor surface 
adhesion or lack of differentiation.  
 
Figure 3.3.8: Morphologies of cell types responsible for glial scar encapsulation and implant 
rejection. Reprinted from Journal of Neuroscience Methods, Volume 148, Issues 1, Vadim S. 
Polikov, Patrick A. Tresco, William M. Reichert, Response of brain tissue to chronically 





Figure 3.3.9: Fluorescence microscopy images showing cytoskeletal arrangement and cell 
morphology. Blue – Nucleus, Red – cytoskeleton, Green – Cytoplasm. Microglia morphologies 






Neural prostheses are becoming more commonly used as a way to signal, stimulate, and 
record neural activity for a variety of disabilities. There has been a body of work on using 
surface topographies of various scales to promote neuron adhesion and interaction 35-39. Several 
studies have reported positive responses of micro and nanoscale surface morphologies, especially 
in controlling axon directionality 35, 39-40. However, a minimal amount of this work has been 
directed towards limiting reactive gliosis and promoting neuron integration for direct electrical 
stimulation. In this study, titania nanotube arrays of two different topographies were analyzed for 
their potential application as interfaces for neural prostheses. The nano architectures were 
compared to their bulk material as a control and previously examined polymer nanowire array 
architecture. The lack of large flat cellular development across the surface of the NT – DEG and 
NW arrays may indicate they are less likely to undergo glial encapsulation than the Ti or NT – 
H2O arrays. The difference in cellular interaction between the two titania nanotube architectures 
indicate that cellular response varies greatly among topographies and may be optimized by 
varying the nanotube array dimensionality. Electrolyte solutions can alter the maximum length as 
well as arrangement of the nanotube arrays, while pore size and length may be controlled by the 
voltage and anodization time respectively. With further study on existing neural cell lineages, 
nano architectures such as NT – DEG arrays may have the potential to limit reactive gliosis in 
neural prosthesis and increase their effectiveness and longevity. Further studies are now aimed to 
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DIFFERENTATION OF C17.2 MURINE NEURAL STEM CELLS ON 






Surface topography on a nano scale can create a biomimetic extracellular 
microenvironment capable of influencing differentiation of progenitor cells 1-2. In this research 
we analyze the effect of surface topography on marker protein expression signifying cellular 
differentiation by immunofluorescent staining. Marker proteins expressing undifferentiated, 
glial, and neuronal cell lineages were stained for. 
When surface topography alone does not induce differentiation, a media containing 
supplements and growth factors may be used to force differentiation. With the use of a nerve 
growth factor, neurotropic factors, and specific supplements, neural progenitor cells can be 
forced in to multiple neural phenotypes 3. This optimized culture condition was used to force 
differentiation of the C17.2 murine neural stem cells on NT - H2O and NT – DEG arrays as well 
as the NW arrays and the control Ti. Forced differentiation allows further analysis of the various 
neural phenotype interactions with surfaces of different scale and topography. This research used 
immunofluorescence staining of marker proteins for undifferentiated, astryocytic, and neuronal 
cell lineages to analyze differentiation. The expressions of these proteins were analyzed using 
ImageJ software to determine the dominant phenotype.  
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4.2 Experimental Methods 
 
4.2.1 Fabrication and Characterization of Nano topographic Surfaces 
 
NW arrays and two topographies of titania nanotube arrays were fabricated as described 
in chapter 2 4-5. In short PCL discs were extruded through alumina nanoporous membranes that 
were then dissolved away leaving nanowire arrays protruding from the bulk substrate. Titania 
nanotube arrays were manufactured using an electrochemical anodization technique on pure 
titanium in a fluoride-containing electrolyte; the samples were then rinsed and annealed to 
produce crystalline titania nanotube arrays of different topographies adhered to the bulk titanium 
substrate. The nano architectures were examined for uniformity and repeatability using SEM 
imaging. The commercially pure Ti underwent the same degreasing and cleaning process as the 
titanium used for the fabrication of nanotube arrays. 
 
4.2.2 C17.2 Cell Culture 
 
Multipotent mNSC subclone C17.2 was generously provided by Evan Y. Snyder, M.D., 
Ph.D. Isolation and culture conditions of this cell type can be found in Section 3.2.2. In short 
these cells were obtained from a mouse cerebellum and transfected to obtain stem-like cells. This 
cell clone has been extensively examined and characterized indicating their accuracy in 
representing the mammalian central nervous system. Low passage 
cells were thawed and cultured in a highly modified, supplemented DMEM in petri dishes, and 




4.2.3 C17.2 Cell Culture on Surfaces 
 
Sample types were sterilized prior to seeding and were seeded onto the surfaces as 
described in Section 3.2.3. In short the samples underwent sterilization in a biosafety cabinet 
before cells from the subculture were seeded at a concentration of 1500 cells/well onto the 
surfaces. After seeding the media was replaced with the standard growth media after 8 hours or 
differentiation media within the first day. The differentiation media was mixed the day of 
seeding and was stored in a 50mL centrifuge tube at 4°C for the duration of the study. Following 
the first media change, subsequent media changes were performed every third day. Media was 
changed by the same procedure as described in Section 3.2.3. Analyses of the cells were carried 
out on days 1, 4, and 7 of culture when grown in normal media and days 4, 7, and 14 of culture 
when in differentiation media. Cell studies included morphology performed through SEM 
imaging of the cells on the surface and differentiation by protein expression of undifferentiated, 
glial, astrocyte, and neuronal immunofluorescent-labeled protein markers. 
 
4.2.4 C17.2 Differentiation Media 
 
In order to induce differentiation of the mNSC subclone C17.2 without coculturing the 
cells with primary neurons, a media containing supplements and growth factors is necessary. 
Recent work has been performed to create culture conditions suited to differentiate C17.2 cells 
for use in toxicity tests 3. These conditions were shown to provide a culture of mixed astrocytes 
and neurons. The differentiation media contained: 
• Serum-free High Modified Dulbecco’s Modified Eagle’s Medium (DMEM)  
o Glucose (4500mg/L), 
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o L-glutamine 
o Sodium Pyruvate 
• 1% L-glutamine (2mM) 
• 1% Penicillin /Streptomycin/Fungazone 
• Ham’s F-12 Nutrient Mixture at a 1:1 ratio with the highly modified DMEM 
• N-2 supplements 
• Brain-derived neurotropic factor (BDNF) at 10ng/mL 
• Nerve growth factor (NGF) at 10ng/mL 
 
 N-2 supplement is a commercially available formulation to support the growth of post-
mitotic neurons in the peripheral and central nervous systems, and is based on Bottenstein’s N-1 
formulation. In this experiment the media was modified to use glial derived neurotropic factor 
(GDNF) rather than BDNF. Research has show that GDNF supports the midbrain dopaminergic 
neurons associated with movement disorders and at high saturation conditions works as well as it 
would in concert or with BDNF alone 6. Saturation conditions of the neurotropic factors for 
select tissues were seen to be 50ng/mL, beginning to plateau at 10ng/mL. Nerve growth factor 
can be found in two molecular forms 7S and 2.5S. It has been shown that the two forms have 
different biological activities with the 7S form promoting the survival and neurite outgrowth of 
neurons in the cortex and cerebellum while promoting the proliferation of astrocytes in vitro, the 
2.5S form was not seen to promote such behavior 7. Therefore NGF 7S was used instead of 2.5S 




4.2.5 Morphology of C17.2 on Surfaces 
 
To study the morphology of the cells as well as their interaction with the surface, SEM 
imaging was performed on the specified days after seeding. Fixing was performed as stated in 
Section 3.2.6. In short cells were removed from media, fixed and dehydrated, and were allowed 
to air dry before being stored in a desiccator until imaging. Surfaces were coated with 10 nm of 
gold, and imaged at 7kV for the NW array surfaces and 15 kV for the Ti and titania nanotube 
arrays. 
 
4.2.6 C17.2 Marker Protein Expression 
 
 Indirect immunofluorescence staining was used to measure the cellular differentiation 
through marker protein expression displayed by different neural cell types 8. On each day of 
interest of the study the cell rich media was aspirated to remove any unbound cells. Each sample 
was then carefully rinsed twice with PBS before being transferred to a new well of equivalent 
size containing 3.7% formaldehyde in PBS. Samples were incubated in this fixative for 15 
minutes before undergoing two five-minute PBS rinses in their current well and a third in a new 
well. After rinsing, 1% Triton X in PBS was added to the wells for three minutes to permeabilize 
the cell membrane. Permeabilization was followed by a PBS wash. Nonspecific immune reaction 
binding was blocked by incubating the samples in a 10% BSA in PBS solution for 30 minutes at 
room temperature.  To selected samples, primary antibody was added. Either heavy 
neurofilament (NF-H, Santa Cruz Biotechnology) a differentiated post-mitotic neuronal cell 
marker, or glial fibrillary acidic protein (GFAP, Santa Cruz Biotechnology) a Type 1 Astrocyte 
marker were added at a dilution of 1:100 with nestin (10µg/mL, Neuromics), a neural progenitor 
cell/undifferentiated neural cell marker was added to 2% BSA in PBS. Samples were incubated 
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in primary antibody solution at 20°C overnight. Following incubation the wells were aspirated 
and samples rinsed three times with PBS before the fluorescently labeled secondary antibody 
was added (dilution 1:200, Santa Cruz Biotechnology) along with 2% BSA in PBS and incubated 
at room temperature for 45 minutes before aspiration. The samples were then incubated at room 
temperature in a 300nM DAPI nucleus stain in PBS for five-minutes before undergoing a two 
PBS rinses. Samples were kept in PBS at 20°C until fluorescent imaging with DAPI 49 BP 
585/50 blue filter, 62 HE BP 585/35 Red filter, and BP 474/28 green filter on a Zeiss 
fluorescence microscope. Images were analyzed using the ImageJ software.  
 
4.2.7 C17.2 Marker Protein Expression When Grown In Differentiation Media 
 
Indirect immunofluorescent staining was used to measure the cellular differentiation 
through marker protein expression displayed by different neural cell types 8.  Each day of interest 
was prepared as described in Section 4.2.6 with alternative primary antibodies. Light 
neurofilament (NF-L, Neuromics) was chosen over the previously used heavy neurofilament 
(NF-H) due to NF-L’s abundance as it acts as the backbone to which the other neurofilaments 
copolymerize 9. Aldehyde dehydrogenase 1 family, member L1 (ALDH1L1, Neuromics) was 
used in place of GFAP as it a highly specific marker for astrocytes with a broader pattern of 
expression 10. Each of these markers were added at a dilution of 1:1000 with nestin (10µg/mL, 
Neuromics), a neural progenitor cell/undifferentiated neural cell marker at a dilution of 1:250 to 
2% blocking serum in PBS. Staining continued as described in Section 4.2.6 for days 4, 7, and 
14 of culture, with imaging being performed on a Zeiss fluorescence microscope with DAPI 49 
BP 585/50 blue filter, 62 HE BP 585/35 Red filter, and BP 474/28 green filter. 
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4.2.8 Statistical Analysis 
 
Each experiment was performed on three samples per surface with at least two different 
cell populations (nmin = 6). The quantitative results were analyzed using the analysis of variance 
(ANOVA) model with an unpaired Tukey’s post hoc test with statistical significance a p < 0.05. 
The analysis was performed using Minitab. 
 
4.3 Results and Discussion 
 
In order to verify the activation or expression and bio-integration of the material with cell 
type or tissue, cellular differentiation was studied using immunofluorescence staining. This 
method allows visualization of the presence of cell-specific proteins that are used to indicate 
cellular differentiation lineages. Previous studies have identified proteins expressed by the 
different cell types 3, 8, 11-13 critical in neural prosthesis integration. 
Neural stem cells are known to express nestin if they remain in the stem cell state, or in 
the form of multiple progenitor and precursor lineages 8. Nestin is a type of intermediate filament 
expressed in nerve cells and is involved in the growth of axons; it is usually transient and is 
down regulated in mature neural cells. nestin may be up regulated as a result of neural tissue 
injury and the formation of glial scar tissue. 
Glial fibrillary acidic protein (GFAP) is another intermediate filament, but is a common 
marker for astrocytes as well as ependymal cells. This filament is involved in the structural and 
functional properties of the cytoskeleton, maintaining cellular shape and strength. Some research 
has shown GFAP plays key roles in astrocyte-neuron interaction, allowing for neuron extensions 
to form 14. Most notably GFAP has been linked to the repair of neural tissue after injury, forming 
glial scar tissue 15 and resulting in fibrous encapsulation. 
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Neurofilament markers such as heavy neurofilament (NF-H) indicate differentiated post-
mitotic neuronal cells. The expression of these neurofilaments is directly correlated to axonal 
diameter and electrical signal transduction 16. The expression of these marker proteins was 
determined for days 1, 4, and 7 of culture by immunofluorescence for C17.2 cells grown on the 
control, comparison and nanotube arrays.  
 
Table 4.3-1: Blocking agents, primary, and secondary antibodies used for immunofluorescence 
identification of C17.2 differentiation when grown in standard growth media.  
 Undifferentiated 
Marker Astrocyte Marker Neuron Marker 



















Figure 4.3.1: Immunofluorscence of C17.2 mNSC’s grown in standard growth media. Blue 
(DAPI) – Nucleus, Green (FITC) – nestin (undifferentiated), Red (TR) – NF-H (neurons). 
  
 The immunofluorescence images show a sizeable expression of the undifferentiated 
marker nestin for all samples types. It is clearly apparent that Ti and NT – H2O array samples 
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have reached confluence while the NW arrays and NT – DEG arrays show more dispersed cells. 
No significant amount of neuronal indicator is seen in Figure 4.3.1. Fluorescent images showing 
the astrocyte and neuron markers are withheld as neither marker was expressed at concentration 
high enough to be seen, with only the nucleus fluorescing. These findings indicate that over the 
span of the study, with the growth parameters used, the C17.2 mNSC’s are not forced into 
differentiation by the nano architecture alone or illicit specific cellular responses. 
Cell morphology was studied on 4 and 7 days of culture in differentiation media through 
the use of a SEM to visualize the cellular interaction with the surfaces and can be seen in Figure 
4.3.2. The most notable difference when grown under differentiation conditions is the hindered 
proliferation, allowing single cell analysis. All surface types showed more direct cellular 
interaction with the surface, however with time the Ti samples continued to have large flat cell 
bodies covering the surface, which is indicative of oligodendroglia 13, 17. NW array interfaces 
showed a combination of flat and bipolar cells, indicating early stages of differentiation.  The 
differences in NW array architectures arise from larger membrane pore size being used as a 
result of supply issues, the size of the nanowires have been seen to not have a significant impact 
on cellular interaction 18.  NT – H2O arrays showed long cellular extensions at day 7 of culture, 
but did not have extensive interaction with the nano architecture. NT – DEG arrays show cellular 
extensions beginning to form, with much greater interaction with the nano architecture. The 
titania nanotube arrays both show compact circular cell structures which may indicate that only 




Figure 4.3.2: SEM images at lower and higher magnification of days 4 and 7 when grown in 
differentiation media. Ti samples exhibit the same large flat cell morphologies as without 
differentiation media. Nano architecture surfaces show less morphological differentiation cues. 
Cellular interaction with the nano structures of NT – DEG samples is pronounced.  
 
In order to verify the activation or expression and bio-integration of the cell type or tissue 
with the material, cellular differentiation was studied using immunofluorescence staining. This 
method allows visualization of the presence of cell-specific proteins that are used to indicate 
cellular differentiation lineages. Previous studies have identified proteins expressed by the 
different cell types 3, 8, 10-13, 19 critical in neural prosthesis integration. 
As mentioned earlier, nestin was used as a marker protein for undifferentiated neural 
cells, and proves that these cells are still neuronal and have not become fibroblastic 8.  
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ALDH1L1 has been seen as a highly specific marker for astrocytes including cortical 
astrocytes with a broader pattern of expression than other common markers such as GFAP 10, 20. 
ALDH1L1 plays an important role in many biochemical reactions and has a major impact on cell 
division and growth 21. 
Neurofilament markers such as light neurofilament (NF-L) indicate differentiated post-
mitotic neuronal cells. The expression of these neurofilaments is directly correlated to axonal 
diameter and electrical signal transduction 16. NF-L was chosen over the previously used NF-H 
due to NF-L’s abundance as it acts as the backbone to which the other neurofilaments 
copolymerize 9. 
With differentiation media cellular proliferation is delayed, therefore the expression of 
these marker proteins was determined for days 4, 7, and 14 of culture by immunofluorescence 
for cells grown on the control, comparison and nanotube arrays. The expression of each marker 
was analyzed using ImageJ. 
  
Table 4.3-2: Blocking, primary, and secondary antibodies used for undifferentiated, astrocyte, 
and neuronal cells cultured in differentiation media.  
 Undifferentiated 
Marker Astrocyte Marker Neuron Marker 



















Figure 4.3.3: Immunofluorescence of C17.2 mNSC’s cultured in differentiation media for 4, 7, 
and 14 days. Low (10x) and high (50x) magnification are shown for each day. Blue - Nucleus, 




Figure 4.3.4: Immunofluorescence montage of each sample type after culture in differentiation 
media for 7 days. Images are shown at a magnification of 20x. Red – Astrocyte, Green – 
Undifferentiated, Blue – Nucleus.  
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Culturing the C17.2 line in differentiation media was seen to affect cell morphology as 
well as protein expression far more than the non-differentiation media. A significant level of 
astrocyte marker was seen on the NT – DEG samples compared to the NW array samples as 
noted in Figure 4.3.7 on day 7. At this point the cell cultured on Ti surfaces showed a great deal 
of similarity to cells grown on Ti without differentiation media, further supporting the 
morphologies seen in Figure 4.3.2. nestin was still expressed on all surfaces indicating the cells 
have not completely differentiated. The NT – DEG samples showed a larger portion of cells with 
polar extensions compared with the other surfaces, which may indicate early differentiation in 




Figure 4.3.5: Immunofluorescence of C17.2 mNSC’s cultured in differentiation media for 4, 7, 
and 14 days. Low (10x) and high (50x) magnification are shown for each day. Blue - Nucleus, 




Figure 4.3.6: Immunofluorescence montage of each sample type after culture in differentiation 
media for 7 days. Images are shown at a magnification of 20x. Red – Neuron, Green – 
Undifferentiated, Blue – Nucleus.  
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A significant level of neuronal marker was seen on the NT – DEG samples compared to 
the Ti samples as noted in Figure 4.3.8 on day 7. At this point the cells cultured on Ti surfaces 
showed a great deal of similarity to cells grown on Ti without differentiation, further supporting 
the morphologies seen in Figure 4.3.2 and noted for the expression of astrocyte marker. nestin 
was still expressed on all surfaces indicating the cells have not completely differentiated, 
however nestin seemed to be down regulated on NW and NT – DEG surfaces in comparison to 
Ti and NT – H2O. The NT – DEG samples showed more pronounced and elongated extensions 
as compared with the other surfaces. In conjunction with earlier noted morphologies this further 
indicates differentiation in the direction of neurons on the NT – DEG surfaces. 
 
 
Figure 4.3.7: Protein expression of astrocyte marker normalized by cell count. Day 7 shows 
significantly higher expression of astrocyte marker on NT – DEG than NW arrays (#, p < 0.05). 
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Figure 4.3.8: Protein expression of neuronal marker normalized by cell count, Day 7 shows 





The initial results do not show any definite differentiation solely induced by the nano 
architecture and thus will not entice neural stem cells to undergo differentiation at the site of 
implantation without the aid of other molecular cue the astrocyte marker ALDH1L1 and neuron 
marker NF-L were more easily detectable than GFAP and NF-H as suggested in literature. 
Differentiation into multiple neural phenotypes was seen to prevail on NT – DEG surfaces as 
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CHAPTER 5 






Chronic neural prostheses have an amazing potential in aiding many with disabilities, 
ranging from those with auditory and visual to cognitive or even motor control disabilities. 
However the effective longevity of these devices have been limited thus far. These neural 
prostheses are in constant contact with neural tissue in order to record or signal activity in the 
brain. While the failure of the device itself does occur, the main cause of the limited longevity is 
tissue integration with the prostheses. Insertion of the device into the brain tissue causes trauma 
and loss of live tissue. The introduction of the device through the blood brain barrier may expose 
the implant to unfavorable blood proteins that can cause an increase in immune response. After 
the surgery has been performed the body does not see the implant material as natural, and thus a 
response occurs in the form of glial encapsulation in attempt to isolate the implant. The glial scar 
tissue is composed of a dense layer of reactive astrocytes, which form an insulated layer between 
the electrode and the target neuron population, preventing effective signaling or recording at 
these sites. Recently there has been increased interest in exploring how the surface of these 
implants can interact with neural tissue including guiding the direction of neurite outgrowth 
using microscopic features. However, very little work has been done using nanoscale surfaces 
modifications to reduce the immune response and glial encapsulation of the electrode. The 
simple fabrication, biomimetic nano architecture, electrical conduction, and potential for drug or 
growth factor delivery identify titania nanotube arrays as promising interfaces for chronic neural 
prosthetics.  
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This research examined titania nanotube arrays of two different topographies for their 
potential application as interfaces for chronic neural prostheses. This work reports on the effect 
of a densely packed, confluent arrangement and uniform, vertically oriented, high aspect ratio 
titania nanotube arrays on mNSC C17.2 adhesion, proliferation, viability, morphology, and 
differentiation. These topographies were studied in comparison to a bulk titanium control and a 
previously explored biodegradable polycaprolactone nanowire array. The titania nanotube arrays 
were fabricated using an anodization process in two different fluoride containing electrolyte 
solutions. Characterization of nano architecture, crystal structure, wettability, conductance, 
hardness, and protein adsorption were performed using SEM, GAXRD, contact angle, four point 
probe, nano indentation, and micro-BCA assay respectively. Differences surface properties were 
seen between the two titania nanotube arrays, with the NT – DEG arrays showing a higher 
surface energy, more conductive anatase crystal structure with a higher conductivity, softer nano 
architecture, and significantly higher adsorption of favorable neuronal binding proteins. These 
characteristics are in line with beneficial neural integration properties. 
Neural cell functionality using a model murine neural stem cell subclone C17.2 was 
investigated in terms of cellular adhesion, proliferation, viability, morphology, and 
differentiation in addition to protein adsorption. Cellular functionality was studied on 1, 4, and 7 
days of culture using fluorescence microscopy, cell viability assay, indirect immunofluorescence 
and scanning electron microscopy. The results reported in this study show preferential cellular 
adhesion and proliferation on more conductive surfaces with a hierarchal surface structure such 
as the NT – DEG arrays. However differentiation was not seen to occur solely due to the surface 
structure. These results indicate that the neural cell response to different nano topographies will 
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vary, with both types being beneficial for cell binding, but having no affect on cellular response 
that may force glial encapsulation or direct neuron adhesion.  
Altering the growth condition to force differentiation into multiple neural lineages by the 
use of differentiation media allowed the study of the lineage specific interaction with nano 
architecture surfaces. Cellular functionality was analyzed after 4, 7, and 14 days of culture in 
differentiation media. SEM and indirect immunofluorescence were used to perform 
morphological and differentiation studies respectively. Cellular morphology on Ti and NT – H2O 
samples displayed much larger flat cells, which is indicative of oligodendroglia. Spindle shaped 
cells with binary extension grew on top of these flat cells on the titania nanotube array surface. 
NW showed compact spherical cells, which may indicate a lack of progression in the direction of 
cellular differentiation. NT – DEG samples showed a range of morphologies including flat cells, 
spindle shaped binary extension cells, and multi extension cells all of which had direct contact 
with the nano architecture surface. Immunofluorescence reinforced the observed morphologies. 
Both astrocytes and neurons were seen on both titania nanotube arrays with more neurite 
extension seen on the NT – DEG samples, however no significant difference between the two 
nanotube arrays was found. These results show that neurons are interacting directly with the 
nano architecture of the NT – DEG samples, where astrocytes are still necessary to establish 
growth on the NT – H2O samples.  
The results of this work suggest the improved neural integration of neural cells with 
conductive titania nanotube arrays displaying a hierarchical structure. These finding indicate that 
contacts for neural prostheses would establish better neuron adhesion and may prevent glial 
encapsulation of the electrode, extending the implants longevity.  
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5.2 Future Work 
 
It has been seen that producing conductive biocompatible titania nanotube arrays with 
topographies ranging from the nano to microscopic scale provides a promising interface for 
chronic neurological prostheses. Other titanium-based alloys such as titanium nitride (TiN) have 
been used in biomedical applications for there impressive strength and wear resistance and have 
even been tested on primary hippocampal cells 1-2. This material has also been seen to improve 
conductance of titanium ceramics 3-5 and has even been developed into nanotube arrays 
resembling that of the NT – H2O arrays 3-5. Currently the nanotube arrays of the TiN have not 
been studies for biological applications. Further studies could be aimed toward the development 
of TiN nanotube arrays with topographies similar to that of the produced NT – DEG samples to 
improve structural stability, mechanical properties, as well as conductance. In addition future 
research would evaluate the effect of these surfaces on cellular functionality. Including that of 
primary neural and neural stem cells. Upon analyzing those interfaces, the research could be 
carried even further, depositing thin films as contacts on silicon wafers, and growing the nano 
architectures at these contacts. If plausible, in vivo modeling could be performed in mice to 
understand the direct interaction of primary cells.  
Thus far nanotube arrays as biomedical interfaces have only been studies based on their 
ease and repeatability of manufacturing. Now that many forms of nano architectures and their 
method of production are understood, a reverse engineering approach could be taken. Analyzing 
natural tissue on the macro, micro, and nano scale and more closely imitating those structures 
when producing biomedical interfaces will allow for situation specific design of effective 
interfaces. This research could help reduce development time of biomedical interfaces before 





1. Cyster, L. A.; Grant, D. M.; Parker, K. G.; Parker, T. L., The effect of surface chemistry 
and structure of titanium nitride (TiN) films on primary hippocampal cells. Biomolecular 
engineering 2002, 19 (2-6), 171-5. 
2. Cyster, L. A.; Parker, K. G.; Parker, T. L.; Grant, D. M., The effect of surface chemistry 
and nanotopography of titanium nitride (TiN) films on primary hippocampal neurones. 
Biomaterials 2004, 25 (1), 97-107. 
3. Du, H. X.; Xie, Y. B.; Xia, C.; Wang, W.; Tian, F., Electrochemical capacitance of 
polypyrrole-titanium nitride and polypyrrole-titania nanotube hybrids. New J Chem 2014, 
38 (3), 1284-1293. 
4. Jiang, Q. W.; Li, G. R.; Gao, X. P., Highly ordered TiN nanotube arrays as counter 
electrodes for dye-sensitized solar cells. Chemical communications 2009,  (44), 6720-2. 
5. Shang, C. Q.; Dong, S. M.; Wang, S.; Xiao, D. D.; Han, P. X.; Wang, X. G.; Gu, L.; Cui, 
G. L., Coaxial NixCo2x(OH)(6x)/TiN Nanotube Arrays as Supercapacitor Electrodes. 
ACS nano 2013, 7 (6), 5430-5436. 
 
